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Summary 
Eukaryotic nuclear transcription is carried out by three different Polymerases (Pol), Pol I, 
Pol II and Pol III. Among these, Pol I is dedicated to transcription of the rRNA, which is the 
first step of ribosome biogenesis, and cell growth is regulated during Pol I transcription 
initiation by the conserved factor Rrn3/TIF-IA in yeast/human. A wealth of structural 
information is available on Pol II and its general transcription factors (GTFs). Recently, also 
the architectures of Pol I and Pol III have been described by electron microscopy and the 
additional subunits that are specific to Pol I and Pol III have been identified as orthologs of 
the Pol II transcription factors TFIIF and TFIIE. Nevertheless, we still lack information about 
the architecture of the Pol I initiation complex and structural data is missing explaining the 
regulation of Pol I initiation mediated by its central transcription initiation factor Rrn3.  
The Rrn3 structure solved in this study reveals a unique HEAT repeat fold and indicates 
dimerization of Rrn3 in solution. However, the Rrn3-dimer is disrupted upon Pol I binding. 
The Rrn3 structure further displays a surface serine patch. Phosphorylation of this patch 
represses human Pol I transcription (Mayer et al, 2005; Mayer et al, 2004), and a phospho-
mimetic patch mutation prevents Rrn3 binding to Pol I in vitro, and reduces S. cerevisiae 
cell growth and Pol I gene occupancy in vivo. This demonstrates a conserved regulation 
mechanism of the Pol I-Rrn3 interaction. Crosslinking indicates that Rrn3 does not only 
interact with Pol I subunits A43/14, but the interface further extends past the RNA exit 
tunnel and dock domain to AC40/19. The corresponding region of Pol II binds the 
Mediator head (Soutourina et al., 2011) that co-operates with TFIIB (Baek et al, 2006). 
Consistent with this, the Rrn3 binding partner, core factor subunit Rrn7, is predicted to be 
a TFIIB homologue.  
Taken together, our results provide the molecular basis of Rrn3-regulated Pol I initiation 
and cell growth and indicate a universally conserved architecture of eukaryotic 
transcription initiation complexes. 
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 1 Introduction 
1 Introduction 
1.1 Eukaryotic Transcription Systems 
The central dogma of biology describes the transfer of information from DNA to RNA to 
the synthesis of Proteins. The first step of this process is carried out by RNA Polymerases. 
While in archaea and bacteria one polymerase is sufficient to produce all transcripts, in 
eukaryotic systems this process is more elaborate and thus carried out by three distinctly 
specialized polymerase systems that share a partly identical core structure but differ in the 
composition of their additional subunits and their transcription factors (Table 1).   
 
Table 1. Subunits of RNA Polymerases 
 Pol I subunit Corresponding 
subunit in Pol II 
Corresponding 
subunit in Pol III 
 
10 subunit core A190 Rpb1 C160  homolog 
 
A135 Rpb2 C128  homolog 
 AC40  Rpb3 AC40  homolog 
 AC19  Rpb11 AC19  homolog 
 A12.2 Rpb9 C11 homolog 
     
 Rpb5(ABC27) Rpb5 Rpb5 common 
 Rpb6(ABC23) Rpb6 Rpb6 common 
 Rpb8(ABC14.5) Rpb8 Rpb8 common 
 Rpb10(ABC10a) Rpb10 Rpb10 common 
 Rpb12(ABC10b) Rpb12 Rpb12 common 
     
Subcomplex A14/43 A43 Rpb7 C25 counterpart 
 A14 Rpb4 C17 counterpart 
     
Subcomplex 
A49/34.5 
A34.5 TFIIF-ß (Rap30/Tfg2) C53 Pol I/III specific 
 A49 N-term TFIIF-α (Rap74/Tfg1) C37 Pol I/III specific 
 A49 C-term TFIIE-ß C34 Pol I/III specific 
  TFIIE-α C82 Pol  III specific 
   C31 Pol  III specific 
Total  14 subunits  12 subunits 17 subunits  
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Pol I is located in the nucleolus and produces the 35S rRNA precursor which is 
cotranscriptionally processed into the 18S, 25S and 5.8S rRNA (Kos and Tollervey, 2010). 
Pol II, residing in the nucleoplasm, synthesizes mainly mRNAs, while Pol III generates small 
non-coding RNAs such as tRNAs, snRNAs and the 5S rRNA, also in the nucleoplasm (Paule 
and White, 2000). Five subunits, Rpb5, Rpb6, Rpb8, Rpb10 and Rpb12 are shared between 
Pol I, Pol II and Pol III, and another five Pol II specific subunits (Rpb1, Rpb2, Rpb3, Rpb11 
and Rpb9) have counterparts in Pol I and Pol III that contain regions of sequence and 
structural similarity. Two additional subunits, the heterodimer Rpb4/7, which are not 
included in the Pol II core complex show homology to the Pol I subunits A43/14.5 (Kuhn et 
al, 2007) and Pol III subunits C17/25 (Jasiak et al, 2006). Pol I additionally comprises the 
heterodimer A49/34.5 which mediates RNA cleavage and stimulates Pol I processivity 
(Geiger et al, 2010) and has a counterpart in the Pol III subunits C37/53 (Kassavetis et al, 
2010; Landrieux et al, 2006). Parts of these subunits have recently been shown to have a 
distant homology to the Pol II transcription factors TFIIF and TFIIE as indicated in Table 1 
(Geiger et al, 2010; Wu et al, 2011). Further, Pol I subunits A49/34.5 are essential for the 
high Pol I loading rates on the rDNA gene through mediating contacts between adjacent 
enzymes and deletions of A34.5 and especially A49 cause dramatical changes in nucleolar 
morphology (Albert et al, 2011). A49/34.5 also seem to play a role in Pol I-Rrn3 complex 
formation and the subsequent release of Rrn3 from the elongating polymerase (Albert et 
al, 2011; Beckouet et al, 2008), although the mechanism of this effect is not yet 
understood.  
Pol III is the largest of the three enzymes and encompasses three further subunits C31, 
C34 and C82 (Wang and Roeder, 1997). Recently it has been postulated that the C82/34 
heterodimer (Lorenzen et al, 2007) is distantly related to TFIIE (Geiger et al, 2010; Lefevre 
et al, 2011). 
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1.1.1 General Transcription Factors (GTFs) 
For efficient initiation Pol II requires the general transcription initiation factors TFIIB, -D, 
-E, -F and -H. The multifunctional factor TFIIB comprises four structural segments: the core 
domain, B-linker, B-reader and an N-terminal Zn-ribbon. The Zn-ribbon stably binds the 
Pol II dock domain, whereas the TFIIB core domain, comprising two cyclin folds, binds TBP 
and DNA. This interaction helps to recruit Pol II to the promoter DNA (Chen and Hahn, 
2003; Nikolov et al, 1995). The B-linker is involved in promoter opening, while the B-
reader assists in open complex formation and recognizes the initiator sequence (Inr), 
thereby enabling correct start site selection (Kostrewa et al, 2009). TFIIB further interacts 
with TFIID, a 15-subunit complex containing TATA box-binding protein (TBP) (Burley and 
Roeder, 1996; Lee and Young, 2000; Yamashita et al, 1993). The essential transcription 
factors TFIIE and TFIIF are located on opposite sides of the Pol II central cleft (Chen et al, 
2007; Eichner et al, 2010) where they affect post-recruitment steps and the transition 
from transcription initiation to elongation (Flores et al, 1991; Yan et al, 1999). TFIIH binds 
promoter DNA downstream of the transcription-bubble and displays a helicase activity 
that assists promoter melting. Further, TFIIH is involved in phosphorylation of the Rpb1 
CTD and finally also enhances promoter clearance by stimulating stalled elongation 
complexes (Coulombe and Burton, 1999; Kim et al, 2000). 
TBP is common to all three polymerases, and TFIIH is not only a Pol II GTF, but also plays 
an essential role in Pol I transcription (Iben et al, 2002). Further, homologies to TFIIF-ß 
(Rap30) have been described for the Pol I subunit A34.5 (Geiger et al, 2010) and for the 
Pol III specific subunit C53 (Wu et al, 2011). The N-terminal domain of Pol I subunit A49 is 
homologous to the Pol II initiation factor TFIIF-α (Rap74) and to the Pol III-specific subunit 
C37, while the C-terminal domain of A49 is homologous to the Pol II initiation factor TFIIE-
β and to the Pol III-specific subunit C34 (Geiger et al, 2010). The Pol I subunit A12.2 seems 
to be the source of an intrinsic cleavage activity and additionally shows sequence 
homology to TFIIS (Kuhn et al, 2007). The Pol III specific initiation factor Brf1 has been 
identified as the homolog of TFIIB (Colbert and Hahn, 1992; Teichmann et al, 2000; Wang 
and Roeder, 1995), while no TFIIB homolog has been reported in the Pol I system to date.  
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Table 2. Pol II general transcription factors. Function and homologies to other transcription systems (Geiger et al, 2010; 
Hahn, 2004; Kuhn et al, 2007; Thomas and Chiang, 2006; Wang and Roeder, 1995). 
GTF  
Pol II 
Sub-
units 
Pol I 
homolog 
Pol III 
homolog 
Function 
TFIIA 2   Stabilizes TBP and TFIID-DNA binding. Blocks transcription inhibitors. 
Positive and negative gene regulation. 
TFIIB 1  Brf1 Binds TBP, Pol II, and promoter DNA. Helps to fix transcription start site. 
TFIID/ 
TBP 
15 TBP TBP Binds TATA element and deforms promoter DNA. Assembly platform for 
TFIIB, TFIIA and TAFs 
TFIIE 2 A49-C-term C34 Binds promoter near transcription start site. May help to open or stabilize 
transcription bubble in open complex 
TFIIF 3 A49-N-term 
A34.5 
C37 
C53 
Binds Pol II and is involved in Pol II recruitment to PIC and in Open 
Complex formation 
TFIIS 1 A12.3  Stimulates intrinsic transcript cleavage activity of RNA Pol II allowing 
backtracking to resume RNA synthesis after transcription arrest; 
stimulates PIC assembly at some promoters 
TFIIH 10   ATPase/helicase necessary for promoter opening and promoter clearance; 
helicase activity for transcription coupled DNA repair; kinase activity 
required for phosphorylation of RNA Pol II CTD; facilitates transition from 
initiation to elongation 
 
1.1.2 Structural studies on eukaryotic polymerase systems 
Today a wealth of detailed structural information is available on Pol II and associated 
factors. Several years ago the core and finally the complete Pol II structure have been 
solved (Armache et al, 2005; Cramer et al, 2001) (Figure 1). Structures for TFIIEα/ß have 
been solved and an evolutionary conservation to archaeal TFE has been demonstrated 
(Meinhart et al, 2003; Okuda et al, 2000), as well as structures of the TFIIF subunits 
Rap30/TFIIFß and Rap74/TFIIFα (Gaiser et al, 2000; Groft et al, 1998; Kamada et al, 2001). 
The location of TFIIF on the Pol II structure was determined by crosslinking (Chen et al, 
2010). The structure of a Pol II-TFIIS complex was elucidated (Kettenberger et al, 2003), 
and finally, also a Pol II-TFIIB complex was structurally described (Kostrewa et al, 2009; Liu 
et al, 2010). 
There are electron microscopy structures available describing Pol I and Pol III indicating 
the locations of the specific subunits A43/14 and A49/34.5 for Pol I (De Carlo et al, 2003; 
Kuhn et al, 2007) (Figure 1) and C17/25 and C53/37 as well as C82/34/31 for Pol III 
(Fernandez-Tornero et al, 2010). The latter complex was described in detail together with 
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the X-ray structure of Maf1, a negative regulator of Pol III transcription (Vannini et al, 
2010) (Figure 1).  
 
 
Figure 1. Current structural models of the three eukaryotic polymerases, front view. 
 
Further, the Pol III transcription factor Brf1 has been identified as the homolog of TFIIB 
(Colbert and Hahn, 1992; Teichmann et al, 2000), and structural information is available 
for both, Brf1 (Juo et al, 2003) and TFIIB (Kosa et al, 1997; Kostrewa et al, 2009; Liu et al, 
2010). Structures of the specific Pol III subunits C17/25 (Jasiak et al, 2006) and C82 (human 
hRPC62) (Lefevre et al, 2010) are available, as well as for the Pol I specific subunits A43/14 
(Geiger et al, 2008; Kuhn et al, 2007) and A49/34.5 (Geiger et al, 2010).  
Besides the GTFs Pol II further requires additional coactivator complexes to enable 
activated transcription, especially the mediator, a 25 polypeptide assembly (Kim et al, 
1994). Several efforts have been made to understand and structurally characterize this 
complex, which is segmented into four different modules: the head, middle, tail and 
kinase module (Kang et al, 2001). The topology of the mediator middle module has been 
described (Koschubs et al, 2010) and structures have been solved for subunits of the 
mediator middle module (Baumli et al, 2005; Koschubs et al, 2009) and head module 
(Imasaki et al, 2011; Lariviere et al, 2006; Lariviere et al, 2008; Seizl et al, 2011). Recently 
the interaction interface between the mediator head module subunit Med17 and Pol II 
has been identified through crosslinking and mutational analysis (Soutourina et al, 2011). 
Despite this wealth of structural data and the many established homologies between the 
systems, we are still lacking a lot of structural information on Pol I. For example, no 
homologous factor to TFIIB has been described in the Pol I system. Structural data is also 
missing for the essential Pol I core factor subunits and the specific initiation factor Rrn3.  
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1.2 rDNA transcription in the context of ribosome biogenesis and function 
1.2.1 Ribosome composition and biogenesis 
Ribosomes are the earliest and most complex molecular machines in an organism, 
providing the basis for protein biosynthesis and thereby sustaining cell growth. Today’s 
ribosomes most likely evolved from protoribosomes that were only made up by RNA 
(Poole et al, 1998). Eukaryotic ribosomes still comprise up to two thirds of RNA and one 
third of ribosomal Proteins, and the formation of peptide bonds is predominantly 
catalysed by ribosomal RNAs that constitute the major architectural and catalytic 
components of the ribosome.  
Ribosome biogenesis occupies a major part of all cellular energy and metabolic effort and 
therefore is tightly regulated in connection to cell growth and proliferation.  
Thus the production of the 25S, 18S and 5.8S rRNAs, which form one single gene 
transcribed by Pol I, and the 5S rRNA encoded on the same locus, but transcribed by 
Pol III, needs to be tightly coregulated.  
All three eukaryotic polymerases are required simultaneously to produce the four 
ribosomal RNAs and more than 70 ribosomal proteins. Thus, 60 % of total transcription in 
rapidly growing cells is devoted to the production of ribosomal RNA (Warner, 1999). One 
yeast rDNA repeat is a 9.1 kb unit, comprising the sequence encoding the 35S rRNA and 
two nontranscribed spacers (NTS) at both ends, separating the 35S rDNA from the 5S rRNA 
gene, which is transcribed by Pol III (Venema and Tollervey, 1999). The 35S operon 
comprises the DNA sequences for the 18S, 5.8S, and 25S rRNAs which are separated by 
the two internal transcribed spacers (ITS), and flanked at either end by two external 
transcribed spacers (ETS) (Figure 2).  
Pre-rRNA processing has been broadly studied in S. cerevisiae and the initial cleavage sites 
of the 35S rRNA, the earliest detectable pre-rRNA, have been described precisely. Splicing 
of the 3’-ETS occurs cotranscriptionally and is followed by cleavage of the 5’-ETS and the 
ITS1. The ITS2, separating the 5.8S and the 25S rRNA gene, is cleaved several steps later. 
Subsequent chemical modifications and further processing steps of the pre-rRNA are 
accompanied and preceded by the assembly of r-proteins (Venema and Tollervey, 1999). 
Small nucleolar RNAs (snoRNAs) facilitate and assist many chemical modification steps in 
the pre-rRNA by correctly positioning the RNA modifying enzymes on the pre-rRNA 
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through base-pairing with the target sequence. SnoRNAs form small ribonucleoprotein 
particles (snoRNPs) in the cell (Kiss, 2001). Most of the chemical modifications during 
rRNA processing involve 2’-O-methylation of the sugar moiety and pseudouridylation of 
uridine residues (Granneman and Baserga, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
Ribosome assembly, which also starts cotranscriptionally, is mediated by several 
additional proteins and is important to establish the complex folding of the mature rRNAs 
(Granneman and Baserga, 2004). Yeast cells package the primary pre-rRNA transcript into 
large 90S complexes, which can be observed as a terminal knob in Miller chromatin 
spreads (Miller and Beatty, 1969; Russell and Zomerdijk, 2005) (Figure 2). The 90S pre-
ribosomes are then further processed to develop into 43S and 66S particles, precursors of 
the final 40S and 60S ribosomal subunits. The 43S pre-ribosomes are further processed to 
the final 40S subunit in the cytoplasm, whereas the 66S preribosomes are subjected to 
several maturation steps directly in the nucleus before their export to the cytoplasm 
(Granneman and Baserga, 2004; Tschochner and Hurt, 2003). 
Although the precursor of the 18S, 28S and 5.8S rRNA is synthesized by Pol I and the 
precursor of the 5S rRNA is independently synthesized by Pol III, the 28S, 5.8S and 5S rRNA 
finally assemble together with 46 r-proteins to the large ribosomal subunit, while the 18S 
Figure 2. upper panel: electron microscopic image of a yeast nuclear chromatin spread (‘Miller Spread’) Proteins 
associated with growing rRNA strands are stained. Promoter (P) terminator (T), intergenic spacer (IGS). 
lower panel: representative eukaryotic rDNA repeat. The rRNA genes form a single transcription unit that yields the 
35S precursor rRNA which is in part cotranscriptionally processed into the 18S, 5.8S and 28S rRNA (28S rRNA ≡ 25S in 
yeast)(Russell and Zomerdijk, 2005). The 5S rRNA is also encoded on the same locus, but transcribed by Pol III, and 
thus not depicted in this figure. 
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rRNA forms the small ribosomal subunit together with 32 r-proteins (Ferreira-Cerca et al, 
2007).  
As a consequence of the exceptionally high synthetic effort made by the Pol I transcription 
machinery, this is a central point for the control of cell growth and proliferation and was 
identified and investigated as a target for the treatment of cancer, with several tumor 
suppressors and oncogenes targeting this process (Drygin et al, 2010; White, 2005). 
 
1.2.2 rRNA production 
Synthesis of the precursors of the 18S, 25S, 5.8S and 5S rRNAs, that are transcribed by 
Polymerases I and III, is under control of extracellular signaling cascades triggered by 
nutrient deprivation or other cellular stress, in order to keep the balance between the 
growth state of the cell and accumulation of rRNAs. Regulation of the transcription 
machineries in response to cell proliferation and growth factor signaling is essential to 
assure production of all four rRNAs at approximately equimolar levels. This is 
accomplished at different stages of transcription, on an epigenetic level (see also 1.4.1) or 
through control of transcription from each active gene by modification of transcription 
factors.  
There are several kinase pathways targeting Pol I and Pol III adjunct factors. In the Pol III 
system, TOR-dependent regulation of transcription is achieved through phosphorylation of 
the repressor Maf1 which strongly binds to the polymerase only in its dephosphorylated 
form and thereby inhibits transcription initiation (Towpik et al, 2008). 
The Pol I initiation system is regulated mainly through phosphorylations of UBF, CF and 
Rrn3. So far, this has mainly been studied in mammalian systems, which will be discussed 
in detail in chapter 1.3.3 and 1.4.1. Further, a certain phosphorylation pattern of the 
Polymerase may be required for stable interaction with Rrn3 and hence transcription 
initiation. Several phosphorylation sites in mammalian Rrn3 have been reported in the last 
years. Details on this topic are discussed in chapter 1.4.  
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1.3 RNA Polymerase I transcription initiation complex 
1.3.1 Organization of the rRNA genes 
The nucleolar organizing regions are made up by approximately 150 copies of rRNA genes, 
which are arranged in clusters of tandem head-to-tail repeats (Russell and Zomerdijk, 
2005) (see also Figure 2). In yeast and mammals the rDNA promoter comprises 
approximately 150 bp upstream of the transcription start site. Usually, these promoters 
contain two sequence elements, the upstream element (UCE/ UE) and the core promoter 
element (core/ CE) (Boukhgalter et al, 2002; Hamada et al, 2001) (reviewed in (Moss et al, 
2007)). Despite little sequence conservation in this region, all systems require TATA 
binding protein (TBP) and a group of TBP associated factors (TAFs) to recognize the 
promoter as a precondition for transcription initiation. However, besides some similarities 
the required TAFs can differ dramatically in composition and function between yeast and 
higher eukaryotes. 
 
1.3.2 Initiation complex formation in mammals 
Prior to the onset of Pol I transcription, a pre-initiation complex is assembled close to the 
transcription start site, comprising the upstream binding factor (UBF) and the promoter-
selectivity factor (SL1). Mammalian UBF is a 97 kDa HMG-1 box protein with specific DNA 
binding capabilities, which is highly conserved in vertebrates. UBF helps to preserve rDNA 
gene activity and architecture through binding the promoter, the enhancer and the rDNA 
throughout the transcribed region (Denissov et al, 2011; Russell and Zomerdijk, 2005). 
SL1, an initiation factor comprising the subunits Taf1110/95, TAF168/63, TAF148, TAF141 
and TBP (Comai et al, 1992; Gorski et al, 2007), is assembled at the promoter region, and 
provides promoter specificity by binding promoter DNA and UBF. Together these factors 
build up a stable complex. UBF binds and recruits SL1 via its C-terminal domain through a 
phosphorylation-dependent interaction, which is probably enhanced by casein kinase II 
phosphorylation (Kihm et al, 1998; Kwon and Green, 1994; Tuan et al, 1999; Voit et al, 
1992). Further possible interactions between UBF and SL1 are discussed to occur either 
through a direct contact or through induced changes in DNA structure (Jantzen et al, 
1992). The last step prior to transcription initiation is the recruitment of Pol I in complex 
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with the initiation factor TIF-IA, a phosphoprotein which is highly regulated with several 
signaling pathways converging on the control of this interaction (Drygin et al, 2010). 
 
1.3.3 Initiation complex formation in yeast 
The yeast Pol I initiation machinery differs substantially from the mammalian system 
although there are still some parallels. The factors that assemble at the upstream 
promoter element comprise two histones H3 and H4, an uncharacterized 30 kDa protein 
(UAF30) and the non-essential factors Rrn5, Rrn9 and Rrn10 (Keys et al, 1996), together 
they form the upstream activating factor (UAF). These subunits interact with TBP, the only 
factor common to all eukaryotic transcription systems, that is required for recruitment of 
the core factor and efficient transcription (Steffan et al, 1996). Subsequent to TBP binding, 
the core factor (CF), comprising the essential subunits Rrn6, Rrn7 and Rrn11, assembles at 
the core promoter element whereupon all three subunits interact with TBP (Bordi et al, 
2001; Keener et al, 1998; Lalo et al, 1996; Moss et al, 2007; Steffan et al, 1996). The yeast 
core factor subunits Rrn6, Rrn7 and Rrn11 resemble the human SL1 subunits TAF1110, 
TAF168 and TAF148. No yeast homolog to the fourth mammalian SL1 subunit TAF141 has 
been described so far.  
Similar to the mammalian system, Pol I is finally recruited to the rDNA promoter together 
with the central transcription initiation factor Rrn3, the yeast homolog of TIF-IA (Bodem et 
al, 2000; Moorefield et al, 2000). The Pol I–Rrn3 interaction also appears to be phospho-
regulated, but the underlying mechanisms are less understood and fewer details are 
known about possible phosphorylation sites. 
 
Table 3. Pol I initiation Factors 
 
 
 
 
 
 
 
Yeast  Mammals 
Core factor (CF) TIF-IB/ SL1 
Rrn6 Taf1110/95 
Rrn7 TAF168/63 
Rrn11 TAF148 
Upstream activating factor (UAF)  
Rrn5, Rrn9, Rrn10, UAF30, H3, H4 UBF 
TBP TBP 
Rrn3 TIF-IA 
Figure 3. Assembly of the Pol I initiation complex, 
adapted from (Moss et al, 2007). 
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1.4 Regulation of RNA Polymerase I transcription  
1.4.1 General mechanisms that control rRNA transcription  
Regulation of RNA Polymerase I transcription in response to cellular signals can be 
achieved at two levels. On the one hand the number of active genes can be regulated on 
an epigenetic level, or, as a short-term response the rate of transcription from each active 
rRNA gene is adjusted. In growing yeast cells, only half of the rRNA genes are active, and 
these are randomly distributed over the rRNA gene locus (Dammann et al, 1995). NoRC, a 
nucleolar remodeling complex that consists of the ATPase SNF2h and TIP5 (TTF-1-
interacting protein-5), silences rRNA genes through recruitment of a DNA 
methyltransferase, a histone deacetylase and a histone methyltransferase. NoRC thereby 
leads to changes in chromatin structure and establishment of a heterochromatic state of 
the rDNA promoter, by mediating methylation of the Lys9 residue of histone H3 and by 
causing histone hypoacetylation and DNA methylation in a certain temporal order (Guetg 
et al, 2010; Santoro et al, 2002) (Santoro and Grummt, 2005). Further, in response to 
nutrient starvation, TOR kinase regulates association of Rpd3-Sin3 histone deacetylase 
(HDAC) with rDNA chromatin, thereby controlling acetylation of histone H4. 
Hypoacetylation of H4 leads to loss of nucleolar structure and RNA Pol I delocalization 
(Tsang et al, 2003). 
Control of rRNA production is also achieved through alterations in the rate of transcription 
from each active gene. In mammalian systems, in contrast to yeast, rDNA transcription is 
regulated in a cell-cycle dependent manner. SL1 subunit TAF1110 is phosphorylated by 
cdc2/ cyclin B, leading to SL1 inactivation, loss of interaction with UBF and mitotic 
repression of rRNA synthesis (Heix et al, 1998). Moreover, PIC assembly and stability is 
regulated through UBF phosphorylation levels, with kinetics slightly different from SL1 
phospho-regulation (Klein and Grummt, 1999). These events together lead to a cell-cycle 
dependent regulation of rDNA transcription in mammals. 
Another target for transcriptional regulation is the recruitment of Pol I to the rDNA 
promoter and the PIC. This step is mediated through formation of a stable initiation-
competent Pol I-Rrn3 complex and recruitment of this complex to SL1/CF, and is repressed 
or enhanced through phosphorylation at several distinct positions either on the Pol I or on 
the Rrn3/ TIF-IA surface. 
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1.4.2 Rrn3 interaction with RNA Polymerase I 
Yeast whole cell extracts contain a 17-fold excess of Pol I (15200 copies/cell) compared to 
the Pol I-specific initiation factors UAF and CF (750 and 950 copies/cell, respectively) 
whereas only a three-fold excess compared to Rrn3 (5300 copies/cell). This indicates that 
only a minor fraction of Pol I interacts with UAF and CF during transcription initiation, in 
agreement with the fact that UAF and CF remain bound to the promoter during several 
rounds of transcription which was further proved by ChIP analysis (Bier et al, 2004). 
Whereas the free forms of Rrn3 and Pol I are much more abundant in cellular extracts 
than the other initiation factors, levels of the Pol I-Rrn3 complex, the initiation competent 
form of Pol I, equal the levels of UAF and CF (Bier et al, 2004; Milkereit and Tschochner, 
1998; Yamamoto et al, 1996). While clearly an excess of Pol I is needed for the high 
loading rate of transcribing polymerases on the gene, a reason for the abundant presence 
of Rrn3 remains unclear. Upon elongation, Pol I leaves UAF and CF at the promoter and at 
the same time or shortly thereafter Rrn3 is released as well from the elongating 
polymerase (Bier et al, 2004). The function of Rrn3 is conserved between yeast and higher 
eukaryotes (Bodem et al, 2000; Moorefield et al, 2000).  
Upon Pol I recruitment, Rrn3 interacts with the Pol I specific subunit A43 in S. cerevisiae 
(Peyroche et al, 2000) and in S. pombe with the A43 homolog RPA21, thus this contact 
seems to be evolutionarily conserved (Imazawa et al, 2002). This crucial interaction is 
stabilized by the subunit A14 (Ker1p in S. pombe) (Imazawa et al, 2005). Rrn3 mediates 
recruitment of Pol I to the PIC through an additional interaction with the core factor 
subunits Rrn6/TAF1110 and Rrn7/TAF163 (Miller et al, 2001; Peyroche et al, 2000). Release 
of Rrn3 from elongating Pol I is triggered by the subunits A49/34.5 possibly through 
contacts between adjacent polymerases which are packed tightly on the rDNA strand 
upon entering the elongation phase (Albert et al, 2011; Beckouet et al, 2008) but the 
detailed underlying mechanism remains elusive. Several signaling pathways triggered by 
cellular stress response and growth factors converge on regulation of the interaction 
between Rrn3 and Pol I. Formation of the Rrn3-Pol I complex is necessary for transcription 
initiation in vivo. Nevertheless, free Pol I can be recruited to the rDNA promoter at low 
levels in vitro, but Rrn3 binding is still required for initiation (Aprikian et al, 2001; Schnapp 
and Grummt, 1991; Schnapp et al, 1993). This implicates an additional role for Rrn3 in 
retaining an initiation-competent polymerase after the step of recruitment. 
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1.4.3 Regulation of the Rrn3-Pol I interaction in mammals 
The interaction of Rrn3 (TIF-IA in mammals) with the Pol I complex is regulated by growth 
factor signaling pathways that connect nutrient availability to rRNA production (Drygin et 
al, 2010; Grummt and Voit, 2010), which can accounts for up to 60% of all nuclear 
transcription (Warner, 1999). Signaling cascades trigger phosphorylation and 
dephosphorylation of TIF-IA (Cavanaugh et al, 2002; Drygin et al, 2010). TIF-IA 
phosphorylation at several different positions has been reported to influence on the one 
hand TIF-IA-Pol I complex formation and stability, and on the other hand interaction of 
Rrn3 with SL1. While rapamycin mediated inhibition of TOR kinase causes phosphorylation 
of S199 in TIF-IA, which impairs Pol I-TIF-IA complex formation, dephosphorylation of the 
N-terminal serine S44 as a result of rapamycin treatment leads to translocation of TIF-IA to 
the cytoplasm (Mayer et al, 2004). Phosphorylation of T200 by JNK2 triggered by oxidative 
stress leads to loss of interaction between TIF-IA and SL1 as well as Pol I and translocation 
of TIF-IA from the nucleolus into the nucleoplasm and thereby reduces rRNA gene 
transcription rates (Mayer et al, 2005). Phosphorylation of S170/172 by CK2 leads to 
release of TIF-IA from elongating Pol I and thereby promotes efficient transcription, while 
dephosphorylation by FCP1 allows reassociation of the Pol I-TIF-IA complex, thereby 
initializing a new transcription cycle (Bierhoff et al, 2008; Panova et al, 2006). 
Phosphopeptide mapping further revealed two phosphoserines S633 and S649 that need 
to be phosphorylated by ERK and RSK to retain TIF-IA function (Zhao et al, 2003). In 
contrast to these results, phosphorylation of S635 by AMP-activated protein kinase in 
response to nutrient deprivation inhibits interaction of TIF-IA with SL1 and thereby 
prevents formation of an active transcription initiation complex (Hoppe et al, 2009). 
 
1.4.4 Regulation of the Rrn3-Pol I interaction in yeast 
Control of Rrn3 dependent recruitment and initiation of Pol I has been described and 
understood in less detail in the yeast system than in mammals. However, there is 
evidence, that the free form of Rrn3 is predominantly phosphorylated, whereas 
unphosphorylated Rrn3 is able to stably bind Pol I. In turn, Pol I phosphorylation at specific 
sites seems to be a prerequisite for stable association with Rrn3 and efficient transcription 
initiation (Fath et al, 2001; Gerber et al, 2008). The Pol I-Rrn3 interaction seems to be 
regulated through the TOR kinase or kinases downstream the TOR signaling pathway, as 
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Rapamycin treatment causes a decrease in the amount of Rrn3-Pol I complex, similar to 
the observations in stationary phase (Claypool et al, 2004).  
Rrn3 has been shown to interact with the Pol I specific subunit A43 (Peyroche et al, 2000), 
which is evolutionarily conserved. In agreement, RPA21, the S. pombe homolog of A43, 
has been identified as the interaction partner of S. pombe Rrn3 (Imazawa et al, 2002). 
While in the mammalian system this interaction needs to be disrupted after initiation in 
order to maintain efficient transcription and to keep nucleolar structure (Bierhoff et al, 
2008), in the yeast system a strain with a permanent fusion of A43 to Rrn3 is viable with 
the same growth rates as wild type (Laferte et al, 2006). 
Several phosphosites have been identified on the Pol I surface (Gerber et al, 2008), five of 
which are located in subunit A43, although partly in a non-essential c-terminal region. 
However, two of them, S208 and S220 are situated in a flexible loop after a conserved 
region from P42 to D172, which has been shown to be required for Rrn3 binding 
(Peyroche et al, 2000), and thus might have a regulatory effect on Rrn3-Pol I interaction, 
but this remains speculative. 
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1.5 Aims and scope of this study 
Understanding the architecture of all tree eukaryotic nuclear RNA Polymerases and their 
interactions with associated factors, not only provides a more comprehensive picture on 
how transcription processes are regulated, but also helps us to understand how different 
specificities have evolved. While models for the minimal initiation complexes of Pol II and 
Pol III have been described in the last years (Chen and Hahn, 2004; Kostrewa et al., 2009; 
Liu et al., 2010; Vannini et al., 2010), the architecture of the Pol I initiation complex still 
remains unknown. There are several reasons for this, on the one hand the lack of a known 
TFIIB-related factor in the Pol I system, and on the other hand, the very little knowledge 
on the Pol I initiation factors Rrn6, Rrn7, and Rrn11. Finally, we are also still lacking 
information on the structure of the central Pol I initiation factor Rrn3 and its precise 
position on the Pol I surface.  
To understand how Pol I transcription and cell growth are regulated, structural insights 
into the Pol I-Rrn3 initiation complex are required. 
In this study, a structural and functional approach will be taken to characterize the Rrn3 
protein and its interaction with Pol I. An intermediate goal of this project is to solve the 
crystal structure of Rrn3, purified from an exogenous source. Based on this structure, 
functional studies will be designed, in order to clearly identify interaction sites of Rrn3 
with Pol I. Given that a stable complex between Rrn3 and Pol I will be obtained in vitro, 
crossslinking/mass spectrometry analysis will be utilized to define the exact contact 
points.  
Furthermore, we plan to examine the possibility of a phospho-regulation of the Rrn3-Pol I 
complex, based on published data for the mammalian system.  
A side-goal of this study is to gain further information on the core factor subunits and to 
find possible homologies to Pol II transcription factors, which could finally lead to a new 
model for the Pol I initiation complex. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Bacterial strains 
Bacterial strains used in this study are listed in Table 4. XL-1 Blue cells were used for 
cloning, and Bl21-CodonPlus(DE3)RIL for recombinant protein expression. 
Table 4. E. coli strains used in this work 
Strain  Genotype  Source 
XL-1 Blue rec1A; endA1; gyrA96 ; thi-1 ; hsdR17; supE44 ; elA1 ; lac[F´proAB lacI 
q
ZDM15 
Tn10(Tet
r
)] 
Stratagene 
BL21-CodonPlus 
(DE3)RIL 
B; F−; ompT; hsdS(rB
−
 mB
−
); dcm
+
; Tet
r
; gal λ(DE3); endA; Hte [argU, ileY, leuW, 
Cam
r
] 
Stratagene 
 
2.1.2 Yeast strains 
Yeast trains were obtained from euroscarf and further modified in this work. All strains 
used are listed in Table 5. 
Table 5. S.cerevisiae strains used in this work 
Strain  Genotype  Source 
Rrn3Δ (diploid) BY4743; Mat a/a; his3D1/his3D1; leu2D0/leu2D0; lys2D0/LYS2; 
MET15/met15D0; ura3D0/ura3D0; YKL125w::kanMX4/YKL125w 
Euroscarf 
Y24975 
Rrn3 shuffle BY4743; Mat a; sporulated; his3D1/his3D1; leu2D0/leu2D0; lys2D0/LYS2; 
MET15/met15D0; ura3D0/ura3D0; YKL125w::kanMX4/pRS316-Rrn3 
this work 
 
Rrn3 shuffle/ A190-
TAP 
BY4743; Mat a; sporulated; his3D1/his3D1; leu2D0/leu2D0; lys2D0/LYS2; 
MET15/met15D0; ura3D0/ura3D0; YKL125w::kanMX4/pRS316-Rrn3; YOR341W:: 
YOR341W -TAP-His3MX 
this work 
 
 
Rrn3 shuffle/A43-
TAP 
BY4743; Mat a; sporulated; his3D1/his3D1; leu2D0/leu2D0; lys2D0/LYS2; 
MET15/met15D0; ura3D0/ura3D0; YKL125w::kanMX4/pRS316-Rrn3; YOR340C:: 
YOR340C -TAP-His3MX 
this work 
 
 
Rrn3 shuffle/ A190-
3xHA 
BY4743; Mat a; sporulated; his3D1/his3D1; leu2D0/leu2D0; lys2D0/LYS2; 
MET15/met15D0; ura3D0/ura3D0; YKL125w::kanMX4/pRS316-Rrn3; YOR341W:: 
YOR341W -3xFlag-His3MX 
this work 
 
this work 
Pol I purification 
strain/ GPY2 
From YPH499/500; leu2-Δ1 ade2-101 trp1-Δ63 ura3-52 his3-Δ200; lys2-801 
rpa43Δ::LEU2, pAS22 (Trp1) (A43 with HA and 6-His tag) 
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2.1.3 Oligonucleotides 
Oligonucleotides used in this study for cloning, mutagenesis and sequencing were ordered 
at Thermo Scientific at RP-HPLC quality. A list of all nucleotide sequences can be found in 
Table 6.  
 
Table 6. Oligonucleotides. The name indicates the target gene, restriction sites if encoded in the primer and sites of 
mutations. The species of origin is S.cerevisiae if not indicated differently. 
ID Name sequence 
CB-P001 Fwd Rrn3Nhe1 GGAATTCGCTAGCATGATGGCTTTTGAGAATACAAGTAAACGACC 
CB-P002 Rev Rrn3HindIII  ATTGCTTAAAGCTTTTAGTCATCCGACCCATCACTTTCATATTCC 
CB-P003 Rrn3Strep-Nhe_fwd GGAATTCGCTAGCTGGAGCCACCCGCAGTTCGAAAAAATGATGGCTTTTGAGAAT
ACAAGTAAACGACC 
CB-P004 Rrn3 delta loop 242-323_fwd GAAAAGATTATTTCGATTGATGGAATCAAAGAACTTTCCACC 
CB-P005 Rrn3 delta loop 242-323_fwd GGTGGAAAGTTCTTTGATTCCATCAATCGAAATAATCTTTTC 
CB-P006 Rrn3 N-33 Nhe1_fwd GGAATTCGCTAGCATGGGCCTGGTAACCCTTCAACCAGAGGAG 
CB-P007  Nhe1 Rrn3 delta N 44_fwd GGAATTCGCTAGCGATGAAGTGTTTTCAGCGGCCATGTATAG 
CB-P008 Rrn3 Glu394ALA_fwd CACAACAACAATTAGCACTAATGGATTC 
CB-P009 Rrn3 Glu394ALA_rev GAATCCATTAGTGCTAATTGTTGTTGTG 
CB-P010 Rrn3 Asp405ALA_fwd GTGACACTGATAGCTATTTCGTTTGCC 
CB-P011 Rrn3 Asp405ALA_rev GGCAAACGAAATAGCTATCAGTGTCAC 
CB-P012 Rrn3 Arg452GLY_fwd CGTCCTGGTTGAATGGATACGTTATCGAAAG 
CB-P013 Rrn3 Arg452GLY_rev CTTTCGATAACGTATCCATTCAACCAGGACG 
CB-P014 Rrn3 S444D_fwd CAAATTATTTTCGTTGCAGACTATTTAACGTCCTGGTTG 
CB-P015 Rrn3 S444D_rev CAACCAGGACGTTAAATAGTCTGCAACGAAAATAATTTG 
CB-P016 Rrn3 S448D_fwd CGTTGCAAGCTATTTAACGGACTGGTTGAATAGATACG 
CB-P017 Rrn3 S448D_rev CGTATCTATTCAACCAGTCCGTTAAATAGCTTGCAACG 
CB-P018 Rrn3 S444/448D_fwd CGTTGCAGACTATTTAACGGACTGGTTGAATAGATACG 
CB-P019 Rrn3 S444/448D_rev CGTATCTATTCAACCAGTCCGTTAAATAGTCTGCAACG 
CB-P020 Rrn3 S444A_fwd CAAATTATTTTCGTTGCAGCCTATTTAACGTCCTGGTTG 
CB-P021 Rrn3 S444A_rev CAACCAGGACGTTAAATAGGCTGCAACGAAAATAATTTG 
CB-P022 Rrn3 S448A_fwd CGTTGCAAGCTATTTAACGGCCTGGTTGAATAGATACG 
CB-P023 Rrn3 S448A_rev CGTATCTATTCAACCAGGCCGTTAAATAGCTTGCAACG 
CB-P024 Rrn3 Leu251^Glu320_fwd GAATTAGATGAATTAGGAGGAGGAGAGTTGACGCAGGGAATC 
CB-P025 Rrn3 Leu251^Glu320_rev GATTCCCTGCGTCAACTCTCCTCCTCCTAATTCATCTAATTC 
CB-P026 Rrn3 ΔN_Ser48_start_fwd GTGCAAGACAACAGCTGACAAGATGTCAGCGGCCATGTATAGCAGG 
CB-P027 Rrn3 ΔN_Ser48_start_rev CCTGCTATACATGGCCGCTGACATCTTGTCAGCTGTTGTCTTGCAC 
CB-P028 Rrn3 DeltaC_Pro596_fwd CAGAGTTACTTCCCATATGATCCTTAAGGTCTTTTTTCATAGGTATCTTCG 
CB-P029 Rrn3 DeltaC_Pro596_rev CGAAGATACCTATGAAAAAAGACCTTAAGGATCATATGGGAAGTAACTCTG 
CB-P030 Rrn3 dC617_fwd CATAGAGTGGAGTGAAGCAAGCTAAGGTCTTTTTTCATAGGTATCTTC 
CB-P031 Rrn3 dC617_rev GAAGATACCTATGAAAAAAGACCTTAGCTTGCTTCACTCCACTCTATG 
 
26 
 
 2 Materials and Methods 
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CB-P032 Rrn3 dC596_fwd GTTACTTCCCATATGATCCTTAAAAGCTTGCGGCCGC 
CB-P033 Rrn3 dC596_rev GCGGCCGCAAGCTTTTAAGGATCATATGGGAAGTAAC 
CB-P034 Rrn3 S101A_fwd CTTTTGGATATCTTAGCTAGTAATATCAACAGGATAG 
CB-P035 Rrn3 S101A_rev CTATCCTGTTGATATTACTAGCTAAGATATCCAAAAG 
CB-P036 Rrn3 S101D_fwd CTTTTGGATATCTTAGATAGTAATATCAACAGGATAG 
CB-P037 Rrn3 S101D_rev CTATCCTGTTGATATTACTATCTAAGATATCCAAAAG 
CB-P038 Rrn3 S102A_fwd GGATATCTTATCTGCTAATATCAACAGGATAGAATCC 
CB-P039 Rrn3 S102A_rev GGATTCTATCCTGTTGATATTAGCAGATAAGATATCC 
CB-P040 Rrn3 S102D_fwd GGATATCTTATCTGATAATATCAACAGGATAGAATCC 
CB-P041 Rrn3 S102D_rev GGATTCTATCCTGTTGATATTATCAGATAAGATATCC 
CB-P042 Rrn3 S109A_fwd CAACAGGATAGAAGCCTCCAGGGGAACTTTC 
CB-P043 Rrn3 S109A_rev GAAAGTTCCCCTGGAGGCTTCTATCCTGTTG 
CB-P044 Rrn3 S109D_fwd CAACAGGATAGAAGACTCCAGGGGAACTTTC 
CB-P045 Rrn3 S109D_rev GAAAGTTCCCCTGGAGTCTTCTATCCTGTTG 
CB-P046 Rrn3 S110A_fwd CAACAGGATAGAATCCGCCAGGGGAACTTTC 
CB-P047 Rrn3 S110A_rev GAAAGTTCCCCTGGCGGATTCTATCCTGTTG 
CB-P048 Rrn3 S110D_fwd CAACAGGATAGAATCCGACAGGGGAACTTTC 
CB-P049 Rrn3 S110D_rev GAAAGTTCCCCTGTCGGATTCTATCCTGTTG 
CB-P050 Rrn3 S145A_fwd CATCAAAATCCTTTGCGCGAGTATACCCAAATGGTG 
CB-P051 Rrn3 S145A_rev CACCATTTGGGTATACTCGCGCAAAGGATTTTGATG 
CB-P052 Rrn3 S145D_fwd CATCAAAATCCTTTGCGATAGTATACCCAAATGGTG 
CB-P053 Rrn3 S145D_rev CACCATTTGGGTATACTATCGCAAAGGATTTTGATG 
CB-P054 Rrn3 S146A_fwd CAAAATCCTTTGCTCGGCTATACCCAAATGGTGG 
CB-P055 Rrn3 S146A_rev CCACCATTTGGGTATAGCCGAGCAAAGGATTTTG 
CB-P056 Rrn3 S146D_fwd CAAAATCCTTTGCTCGGATATACCCAAATGGTGG 
CB-P057 Rrn3 S146D_rev CCACCATTTGGGTATATCCGAGCAAAGGATTTTG 
CB-P058 Rrn3 S185A_fwd CTTAAGGATGATTCCCGCCTCGATGGGATTCATAGATAC 
CB-P059 Rrn3 S185A_rev CTTAAGGATGATTCCCGCCTCGATGGGATTCATAGATAC 
CB-P060 Rrn3 S185D_fwd CTTAAGGATGATTCCCGACTCGATGGGATTCATAGATAC 
CB-P061 Rrn3 S185D_rev GTATCTATGAATCCCATCGAGTCGGGAATCATCCTTAAG 
CB-P062 Rrn3 S186A_fwd CTTAAGGATGATTCCCTCCGCGATGGGATTCATAGATAC 
CB-P063 Rrn3 S186A_rev GTATCTATGAATCCCATCGCGGAGGGAATCATCCTTAAG 
CB-P064 Rrn3 S186D_fwd CTTAAGGATGATTCCCTCCGATATGGGATTCATAGATACATATTTGGCC 
CB-P065 Rrn3 S186D_rev GGCCAAATATGTATCTATGAATCCCATATCGGAGGGAATCATCCTTAAG 
CB-P066 Rrn3_Seq600 GGGATTCATAGATACATATTTGGCCAAATTTTTCC 
CB-P067 Rrn3_Seq1100 CACTCTAACAACATTATTTAAAACGCATGTTCTAC 
CB-P068 Rrn3_seqfwd CAGCGGCCATGTATAGCA 
CB-P069 Rrn3 pRS315_fwd-NotI-
complementary 
TACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGGCGGCCGCCCGTTAC
TTACTGTGTTCAAGATGAAGCAACTGTACC 
CB-P070 Rrn3 pRS315_rev-SalI-
complementary 
CTCACTAAAGGGAACAAAAGCTGGGTACCGGGCCCCCCCTCGAGGTCGACCCCCA
CAGAAACTCTTTAATAAGTAGACCTGCG 
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ID Name sequence 
CB-P071 Rrn3 pRS316_fwd-NotI-
complementary 
TACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGGCGGCCGCCCGTTAC
TTACTGTGTTCAAGATGAAGCAACTGTACC 
CB-P072 Rrn3 pRS316_rev-SalI-
complementary 
CTCACTAAAGGGAACAAAAGCTGGGTACCGGGCCCCCCCTCGAGGTCGACCCCCA
CAGAAACTCTTTAATAAGTAGACCTGCG 
CB-P073 TAP genom A190 fwd GAACAATGTTGGTACGGGTTCATTTGATGTGTTAGCAAAGGTTCCAAATGCGGCT
TCCATGGAAAAGAGAAG 
CB-P074 TAP genom A190 rev TCCTTCAAATAAACTAATATTAAATCGTAATAATTATGGGACCTTTTGCCTGCTTTA
CGACTCACTATAGGG 
CB-P075 TAP genom A43 fwd CGTATACGAGGAAAACACCAGTGAAAGCAATGATGGTGAATCGAGTGATAGTGA
TTCCATGGAAAAGAGAAG 
CB-P076 TAP genom A43 rev CCTATATCAATAACGTATATCTTTATTTGTTTTGATTTTTTCTCATTTTTCCCGTCTAC
GACTCACTATAGGG 
CB-P077 R3_Bam/Hind cterm_fwd GAAAGTGATGGATCCGATGACTAAGCTTTTTTTTC 
CB-P078 R3_Bam/Hind cterm_rev GAAAAAAAAGCTTAGTCATCGGATCCATCACTTTC 
CB-P079 pRS315-Rrn3-TAP_fwd GCAAGCGGGGAATATGAAAGTGATGGGTCGGATGACTCCATGGAAAAGAGAAG 
CB-P080 pRS315-Rrn3-TAP_rev CGGGCATGTCTCGAAGATACCTATGAAAAAAGACCTCAGGTTGACTTCCC 
CB-P081 HA genom A190 fwd GAACAATGTTGGTACGGGTTCATTTGATGTGTTAGCAAAGGTTCCAAATGCGGCT
CGTACGCTGCAGGTCGAC 
CB-P082 HA genom A190 rev TCCTTCAAATAAACTAATATTAAATCGTAATAATTATGGGACCTTTTGCCTGCTTAT
CGATGAATTCGAGCTCG 
CB-P083 A43 S208D_fwd GTTTGGGCAAATTTGACTTTGGAAACAGATCTTTGGG 
CB-P084 A43 S208D_rev CCCAAAGATCTGTTTCCAAAGTCAAATTTGCCCAAAC 
CB-P085 A43 S220D_fwd CACTGGGTAGATGATAATGGTGAACCCATTGAC 
CB-P086 A43 S208D_rev GTCAATGGGTTCACCATTATCATCTACCCAGTG 
CB-P087 A43 S262/263D_fwd GGCAATGGCTATAACGACGATCGTTCCCAAGC 
CB-P088 A43 S262/263D_rev GCTTGGGAACGATCGTCGTTATAGCCATTGCC 
CB-P089 A43 S285D_fwd GTATTTGATGACGAAGTTGACATCGAAAACAAAGAGAGCC 
CB-P090 A43 S285D_rev GGCTCTCTTTGTTTTCGATGTCAACTTCGTCATCAAATAC 
CB-P091 Rrn6-NheI_fwd GGAATTCGCTAGCATGAGTGAGGGACAAATTCCAAGCTCAGATGTG 
CB-P092 Rrn6-HindIII_rev ATTGCTTAAAGCTTTTATCCAAACCCCCGGATCCTTTTCTTC 
CB-P093 Rrn11-NdeI_fwd GGAATTCCATATGTTTGAAGTCCCTATAACTTTAACTAATAGG 
CB-P094 Rrn11-NotI_rev ATTGCTTAGCGGCCGCTCACTCACTTGAGTCTTCATCACTG   
CB-P095 Rrn11-NotI-ohneStop_rev ATTGCTTAGCGGCCGCCTCACTTGAGTCTTCATCACTGTAATGC 
CB-P096 Rrn6/11 2step_fwd AATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGTTTGAAGTCCCTATAACTT
TAACTAATAGG 
CB-P097 Rrn6/11 2step_rev GGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTTATCCAAACCCCCGGATCCTT
TTCTTC 
CB-P098 Rrn6 seqfwd_1 CTTTAGAATTGAAAGTGTCC 
CB-P099 Rrn6 seqfwd_2  CATCATTGTCGACCATCC 
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2.1.4 Plasmids 
Plasmids used for recombinant expression of from E.coli were generated by classical 
cloning (Table 7). Inserts were produced via single- or two-step PCR. Point mutations were 
introduces via Quick Change mutagenesis. 
 
Table 7. Plasmids for expression in E. coli 
ID 
 
Type Insert cloning 
   From Restriction sites via 
1686 pET-28b Rrn3 (1-627) genomic DNA NheI, Hind III Classical cloning 
1688 pET-28b Rrn3 (34-627) genomic DNA NheI, Hind III Classical cloning 
1689 pET-21b Strep-Rrn3 (1-627) genomic DNA NheI, Hind III Classical cloning 
1690 pET-28b Rrn3-Δloop plasmid 1686 NheI, Hind III Classical cloning 
1691 pET-28b Rrn3-S444/448D plasmid 1686 NheI, Hind III Quick Change 
1692 pET-28b Rrn3-S444/448A plasmid 1686 NheI, Hind III Quick Change 
1693 pET-28b Rrn3-D405A plasmid 1686 NheI, Hind III Quick Change 
1694 pET-28b Rrn3-R452G plasmid 1686 NheI, Hind III Quick Change 
1695 pET-28b Rrn3-E394A plasmid 1686 NheI, Hind III Quick Change 
1696 pET-28b Rrn3-S145D plasmid 1686 NheI, Hind III Quick Change 
1697 pET-28b Rrn3-S185D plasmid 1686 NheI, Hind III Quick Change 
1698 pET-21b Strep-Rrn3-S185D genomic DNA NheI, Hind III Quick Change 
1699 pET-28b Rrn6 genomic DNA NheI, Hind III classical cloning 
1700 pET-28b Rrn7 genomic DNA NdeI/NotI Stefan Jennebach 
1701 pET-21b Rrn7 genomic DNA NdeI/NotI Stefan Jennebach 
1702 pET-28b Rrn11 genomic DNA NdeI/NotI classical cloning 
1703 pET-28b Rrn6/Rrrn11 genomic DNA NheI/NotI classical cloning 
1704 pET-21b Rrn6/Rrrn11 genomic DNA NheI/NotI classical cloning 
1705 pET-21b A43 genomic DNA NdeI, NotI Sebastian Geiger 
1706 pET-21b A43/14 genomic DNA NdeI, NotI Sebastian Geiger 
1707 pET-21b A43-14_S208D-
S262/263D 
plasmid 1706 NdeI, NotI Quick Change 
1708 pET-21b A43-14QCA S208D-
S262/263D-S285D 
plasmid 1707 NdeI, NotI Quick Change 
1709 pET-21b A43/14QCB S220D-
S262/263D-S285D 
plasmid 1710 NdeI, NotI Quick Change 
1710 pET-21b A43/14 S262/263D-
285D 
plasmid 1706 NdeI, NotI Quick Change 
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Plasmids used for S. cerevisiae complementation assays were generated by yeast in vivo 
recombination (Table 8). 
Table 8. plasmids S. cerevisiae 
ID 
 
Type Insert cloning 
   From Restriction sites Via 
1711 pRS316 5’UTR-Rrn3 
(1-627)-3’UTR 
genomic DNA NotI, SalI yeast in vivo 
recombination 
1712 pRS315 5’UTR-Rrn3 
(1-627)-3’UTR 
genomic DNA NotI, SalI yeast in vivo 
recombination 
1713 pRS315 5’UTR-Rrn3-S444A 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1714 pRS315 5’UTR-Rrn3-S444D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1715 pRS315 5’UTR-Rrn3-S448S 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1716 pRS315 5’UTR-Rrn3-S448D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1717 pRS315 5’UTR-Rrn3-S444/448A 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1718 pRS315 5’UTR-Rrn3-S444/448D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1719 pRS315 5’UTR-Rrn3-S101A 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1720 pRS315 5’UTR-Rrn3-S101D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1721 pRS315 5’UTR-Rrn3-S102A 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1722 pRS315 5’UTR-Rrn3-S102D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1723 pRS315 5’UTR-Rrn3-S109A 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1724 pRS315 5’UTR-Rrn3-S109D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1725 pRS315 5’UTR-Rrn3-S110A 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1726 pRS315 5’UTR-Rrn3-S110D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1727 pRS315 5’UTR-Rrn3-S145A 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1728 pRS315 5’UTR-Rrn3-S145D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1729 pRS315 5’UTR-Rrn3-S146A 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1730 pRS315 5’UTR-Rrn3-S146D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1731 pRS315 5’UTR-Rrn3-S185A 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1732 pRS315 5’UTR-Rrn3-S185D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1733 pRS315 5’UTR-Rrn3-S186A 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
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ID 
 
Type Insert cloning 
   From Restriction sites Via 
1734 pRS315 5’UTR-Rrn3-S186D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1735 pRS315 5’UTR-Rrn3-ΔL251^320 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1736 pRS315 5’UTR-Rrn3-ΔL242^323 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1737 pRS315 5’UTR-Rrn3-ΔN 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1738 pRS315 5’UTR-Rrn3-ΔC617 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1739 pRS315 5’UTR-Rrn3-S614D 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1740 pRS315 5’UTR-Rrn3 -TAP 
(1-627)-3’UTR 
plasmid 1712 NotI, SalI yeast in vivo 
recombination 
1741 pRS315 5’UTR-Rrn3-S145D -TAP 
(1-627)-3’UTR 
plasmid 1740 NotI, SalI yeast in vivo 
recombination 
1742 pRS315 5’UTR-Rrn3-S185D -TAP 
(1-627)-3’UTR 
plasmid 1740 NotI, SalI yeast in vivo 
recombination 
 
 
 
2.1.5 Chemicals 
Table 9 Chemicals used for protein buffer solutions and crystallization 
Chemical Source Application 
ß-Mercaptoethanol Sigma-Aldrich protein buffer 
Dithiotheitol (DTT) Promega protein buffer 
NaF Roth Phosphatase inhibitor 
ß-Phosphoglycerate Sigma-Aldrich Phosphatase inhibitor 
Na-Pyrophosphate (H3NaO7P2) Sigma-Aldrich Phosphatase inhibitor 
PEG 3350 Fluka Crystallization and Yeast genomic Transformation 
K-Na-tartrate Fluka Crystallization 
Li-Acetate Sigma-Aldrich Yeast genomic Transformation 
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2.1.6 Media and additives 
Cultivation media used in this study are listed in Table 10, additives are listed in Table 11. 
Table 10. Media for E. coli and S. cerevisiae cultures 
Media Description Applicaton 
LB 1% (w/v) tryptone; 0.5% (w/v) yeast extract; 
0.5% (w/v) NaCl 
E.coli culture 
TB 12 g Tryptone, 24 g Yeast extract, 4 ml Glycerol E.coli culture 
10 x Additives for TB 2.3% (w/v) KH2PO4, 12.54% (w/v) K2HPO4   E.coli culture 
autoinduction 5052 25% Glycerol, 2.5 % Glucose, 10% a-Lactose E.coli culture 
SOB 2% (w/v) tryptone; 0.5% (w/v) yeast extract; 
8.55 mM NaCl; 2.5 mM KCl; 10 mM MgCl2 
E.coli transformation 
SOC SOB + 20 mM glucose (before use) E.coli transformation 
YPD 2% (w/v) peptone; 2% (w/v) glucose; 1% (w/v) yeast 
extract 
Yeast culture 
Synthetic complete (SC) amino 
acid drop-out medium 
0.69% (w/v) nitrogen base; 0.6% (w/v) CSM amino 
acid drop out mix; 2% (w/v) glucose; pH 5.6-6.0 
Yeast culture 
YPD plates 2% (w/v) peptone; 2% (w/v) glucose; 1% (w/v) yeast 
extract; 2% (w/v) agar 
Yeast culture 
SC amino acid drop-out plates 0.69% (w/v) nitrogen base; 0.6% (w/v) CSM amino 
acid drop out mix; 2% (w/v) glucose; pH 5.6-6.0; 2% 
(w/v) agar 
Yeast culture 
5-FOA Plates SC (-ura) + 0.01% (w/v) uracil; 0.2% (w/v) 5-FOA; 2% 
(w/v) agar 
Yeast culture 
Pre‐sporulation Plates 1% (w/v) KCH3COO; 0.1% (w/v) yeast extract; 
0.079% (w/v) CSM amino acid complete mix; 
0.25% (w/v) glucose; pH 5.6-6.0; 2% (w/v) agar 
Yeast culture 
Sporulation plate 1% (w/v) KCH3COO; 0.079% (w/v) CSM amino acid 
complete mix; pH 5.6-6.0; 2% (w/v) agar 
Yeast culture 
 
Table 11 Additives for E. coli and S. cerevisiae cultures 
Additive Description Stock solution  Applied concentration 
IPTG E. coli induction 1 M in H20 0.5 mM 
Ampicillin Antibiotic 100 mg/ml in H20 100 μg/ml for E. coli culture 
Kanamycin Antibiotic 30 mg/ml in H20 30 μg/ml for E. coli culture 
Chloramphenicol Antibiotic 50 mg/ml in EtOH 50 μg/ml for E. coli culture 
Tetracyclin Antibiotic 12.5 mg/ml in 70% EtOH 50 μg/ml for E. coli culture 
Geneticin (G418) Antibiotic 200 mg/ml in H20 200 μg/ml for yeast culture 
Rapamycin Inhibitor of TOR kinase 2.5 mg/ml in DMSO 0.025 – 0.25 µg/ml for yeast 
kulture 
Cycloheximide Inhibitor of protein biosynthesis 10 mg/ml in H2O 0.1 – 0.5 µg/ml for yeast culture 
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2.1.7 Buffers and solutions 
General Buffers used in this study are listed in Table 12. Buffers for protein purification are 
listed in Table 13-15. 
Table 12 general buffers and solutions 
Name Description  Application 
4x Stacking gel buffer 0.5 M Tris; 0.4% (w/v) SDS; pH 6.8 at 25°C SDS-PAGE 
4x Separation gel buffer 3 M Tris; 0.4% (w/v) SDS; pH 8.9 at 25°C SDS-PAGE 
Electrophoresis buffer 25 mM Tris; 0.1% (w/v) SDS; 250 mM glycine SDS-PAGE 
5x SDS sample buffer 250 mM Tris/HCl pH 7.0 at 25°C; 50% (v/v); glycerol; 
0.5% (w/v) bromophenol blue; 7.5% (w/v) SDS; 
12.5% (w/v) ß-mercaptoethanol 
SDS-PAGE 
Gel staining solution 50% (v/v) Ethanol; 7% (v/v) acetic acid; 
0.125% (w/v) Coomassie Brilliant Blue R-250 
Coomassie staining 
Gel destaining solution 5% (v/v) Ethanol; 7% (v/v) acetic acid  
2x transfer buffer 2.4% (w/v) glycin; 0.8% (w/v) Tris; 40% (v/v) ethanol Wester blotting 
pre‐treatment 
solution 
7.5% (v/v) ß‐mercaptoethanol, 1.85 M NaOH Cell lysis for western blotting 
Loading Buffer 1M Tris-HCl; pH 6.8, 8 % SDS, 10% Glycerol, 14.7 M 
ß-mercaptoethanol, 0.5 M EDTA, 0.08 % 
Bromophenol Blue  
4x SDS loading buffer  
100x PI 0.028 mg/ml leupeptin; 0.137 mg/ml pepstatin A; 
0.017 mg/ml PMSF; 0.33 mg/ml benzamidine; in 
100% EtOH p.a. 
Protease inhibitor mix 
TFB1 30 mM KOAc; 50 mM MnCl2; 100 mM RbCl; 10 mM 
CaCl2; 15% (v/v) glycerol; pH 5.8 at 25°C 
Preparation of chemically 
competent cells 
TFB2 10 mM MOPS pH 7.0 at 25°C; 10 mM RbCl; 75 mM 
CaCl2; 15% (v/v) glycerol 
Preparation of chemically 
competent cells 
LitSorb 18.2% (w/v) D-Sorbitol in TELit, pH8.0 Preparation of competent yeast 
cells and transformation of yeast 
TELit (pH 8.0) 155 mM LiOAc,  10 mM Tris/HCl (pH 8.0), 1mM EDTA Preparation of competent yeast 
cells and transformation of yeast 
LitPEG 40% (w/v) PEG 3350 in TELit, pH 8.0, filter strerilized Preparation of competent yeast 
cells and transformation of yeast 
TBE 8.9 mM Tris; 8.9 mM boric acid; 2 mM EDTA (pH 
8.0,25°C) 
Agarose gels 
6x Loading buffer 10 mM Tris pH 7.6; 0.0015% (w/v) bromphenol blue; 
0.0015% (w/v) xylene cyanol; 60% (v/v) glycerol; 
100 mM EDTA; 1% SDS 
Agarose gels 
PBS 2 mM KH2PO4, 4 mM Na2HPO4, 140 mM NaCl, 3 
mM KCl, pH 7.4 @ 25°C 
General protein buffer 
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Name Description  Application 
50x d‐desthiobiotin (DTB) 125 mM d‐desthiobiotin, in 500 mM Tris pH 8.0 Strep-tag purification 
avidine 50 umol/L Avidin 50% Glycerol 20 mM Tris pH 8.0, 
150 mM NaCl, 10 mM b-ME 
Strep-tag purification 
Salmon Sperm DNA 2 mg/ml Salmon sperm DNA Yeast genomic transformation 
ChIP was buffer 10 mM Tris-HCl at pH 8.0, 0.25 M LiCl, 1 mM 
EDTA, 0.5 % NP-40, 0.5 % Na deoxycholate 
ChIP assays 
ChIP elution buffer 50 mM Tris-HCl at pH 7.5, 10 mM EDTA, 1 % SDS ChIP assays 
TE buffer 10 mM Tris-HCl at pH 7.4, 1 mM EDTA General protein buffer 
 
 
Table 13 Buffers for Rrn3 Purification 
Buffer Description 
Ni-NTA Lysis buffer L 50 mM HEPES [pH 7.8], 0.2 M NaCl, 5 mM Imidazole, 10 % Glycerol, 3mM DTT, 1x 
Protease Inhibitor Mix 
Ni-NTA washing buffer 50 mM HEPES [pH 7.8], 0.2 M NaCl, 20-50 mM Imidazole, 10 % Glycerol, 3mM DTT, 1x 
Protease Inhibitor Mix 
Ni-NTA elution buffer 50 mM HEPES [pH 7.8], 0.2 M NaCl, 150 mM Imidazole, 10 % Glycerol, 3mM DTT, 1x 
Protease Inhibitor Mix 
Strep lysis/washing buffer 50 mM HEPES [pH 7.8], 0.1 M NaCl,  5 mM MgCl2, 10 % Glycerole, 10 mM ß-ME, Protease 
Inhibitor Mix  
Strep elution buffer 50 mM HEPES [pH 7.8], 0.1 M NaCl,  5 mM MgCl2, 10 % Glycerole, 10 mM ß-ME, Protease 
Inhibitor Mix , 1x DTB 
Anion exchange buffer A 50 mM HEPES [pH 7.8], 10 % Glycerole, 5mM DTT. 
Anion exchange buffer B 50 mM HEPES [pH 7.8], 10 % Glycerole, 2 M NaCl, 5mM DTT. 
Gel filtration buffer C 50 mM HEPES [pH 7.8], 10 % Glycerole, 300 mM NaCl, 5mM DTT. 
 
 
Table 14 Buffers for A43/14 Purification 
Buffer Description 
Ni-NTA Lysis buffer L2 150 mM NaCl, 50 mM Tris (pH=7.5), 5 mM DTT, 1x Protease Inhibitor Mix 
Ni-NTA washing buffer 150 mM NaCl, 50 mM Tris (pH=7.5), 5 mM DTT, 60 mM Imidazole, 1x Protease Inhibitor 
Mix 
Ni-NTA elution buffer 150 mM NaCl, 50 mM Tris (pH=7.5), 5 mM DTT, 150 mM Imidazole, 1x Protease Inhibitor 
Mix 
Anion exchange buffer A2 50 mM Tris (pH=7.5), 5 mM DTT 
Anion exchange buffer B2 50 mM Tris (pH=7.5), 5 mM DTT 
Gel filtration buffer C2 100 mM NaCl, 50 mM Tris (pH=7.5), 5 mM DTT 
 
 
34 
 
 2 Materials and Methods 
Table 15 Buffers and additives for Pol I purification 
Buffer Description Additives 
Lysis/ Freezing buffer 150 mM HEPES (pH 7,8) 60mM MgCl2, 30 
% Glycerol, 5 mM DTT, 1x PI 
2 mM Na-Pyrophosphate (H3NaO7P2), 50 mM 
NaF, 5 mM ß-Phosphoglycerate 
Dilution buffer 100 mM Hepes (pH 7,8), 20mM MgCl2, 
400 mM (NH4)2SO4 
2 mM Na-Pyrophosphate (H3NaO7P2), 50 mM 
NaF, 5 mM ß-Phosphoglycerate 
Dialysis buffer (2x) 100 mM KoAc, 40 mM HEPES (pH 7,8), 2 
mM MgCl2, 10 % Glycerol, 10 mM β-
Mercaptoethanol, 1xPI (benzamidine 
&PMSF) 
0.4 mM Na-Pyrophosphate (H3NaO7P2), 5 mM 
NaF, 1 mM ß-Phosphoglycerate 
Res/W1 buffer 1.5 M KoAc, 20 mM HEPES (pH 7,8), 
1 mM MgCl2, 10 % Glycerol, 10 mM β-
Mercaptoethanol, 1x PI 
2 mM Na-Pyrophosphate (H3NaO7P2), 50 mM 
NaF, 5 mM ß-Phosphoglycerate 
W2 buffer 300 mM KoAc, 20 mM HEPES (pH 7,8), 
1 mM MgCl2, 10 % Glycerol, 10 mM β-
Mercaptoethanol 
2 mM Na-Pyrophosphate (H3NaO7P2), 50 mM 
NaF, 5 mM ß-Phosphoglycerate 
E100 buffer 300 mM KoAc, 20 mM HEPES (pH 7,8), 
1 mM MgCl2, 100 mM Imidazole, 10 % 
Glycerol, 10 mM β-Mercaptoethanol 
2 mM Na-Pyrophosphate (H3NaO7P2), 50 mM 
NaF, 5 mM ß-Phosphoglycerate 
MonoQ buffer A3 20 mM HEPES (pH 7,8), 1 mM MgCl2, 10 
% Glycerol, 5 mM DTT 
2 mM Na-Pyrophosphate (H3NaO7P2), 5 mM 
NaF, 5 mM ß-Phosphoglycerate 
MonoQ buffer B3 2 M KoAc, 20 mM HEPES (pH 7,8), 1 mM 
MgCl2, 10 % Glycerol, 5 mM DTT 
2 mM Na-Pyrophosphate (H3NaO7P2), 5 mM 
NaF, 5 mM ß-Phosphoglycerate 
Superose 6 buffer C3 60 mM (NH4)2SO4, 5 mM HEPES (pH 7,8), 
1 mM MgCl2, 0.1 µM ZnCl2, 10 % 
Glycerol, 5 mM DTT 
2 mM Na-Pyrophosphate (H3NaO7P2), 5 mM 
NaF, 5 mM ß-Phosphoglycerate 
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2.2 General Methods 
2.2.1 Preparation and transformation of competent E.coli cells 
Chemically competent E. coli XL1-blue cells were prepared from a 400 ml LB culture. LB 
media, containing Tetracycline, was inoculated to an OD600 of 0.05 with 4 ml over-night 
pre-culture, and grown to an  OD600 of 0.5. The culture was cooled down to 4 °C on ice and 
kept at that temperature for the following steps. Cells were centrifuged at 3200 g for 
10 min, washed with 100 ml TFB1, and centrifuged again. The supernatant was discarded 
and the pellet resuspended in 8 ml TFB2. 50 µl Aliquots were shock-frozen in liquid 
nitrogen and stored at -80 °C. For transformation, 100 ng of a plasmid, or 7 µl of a ligation 
reaction were added to an aliquot of competent XL1-blue cells, incubated for 5-10 min on 
ice, followed by a 50 s heat shock at 42 °C. Subsequently cells were cooled on ice for 
1 min, resuspended in 600 µl LB media, and incubated for 1 h at 37 °C under constant 
shaking at 750 rpm in a thermo mixer (Qiagen). Finally, cells were plated onto selective LB 
plates and incubated over night at 37 °C. 
Electrocompetent E. coli XL1-blue cells were prepared from 1 l culture in SOB media. After 
inoculation of the media, containing Tetracycline, to an OD600 of 0.05 with a 50 ml over-
night pre-culture, cells were grown to a final OD600 of 0.5. The culture was then cooled 
down to 4 °C on ice and kept at this temperature for all following steps. Cells were split in 
250 ml fractions, centrifuged at 3200 g for 10 min, and washed with each 100 ml ice-cold 
sterile water, followed by a second centrifugation step, and resuspension of the cells in 
2.5 ml ice-cold, sterile 10 % (v/v) glycerol. 50 µl aliquots were flash-frozen in liquid 
nitrogen and stored at -80 °C. For transformation 50 ng plasmid or 7 µl of a ligation 
reaction were added to an aliquot of competent cells, which were then transferred to a 
pre-cooled electroporation cuvette (Bio-Rad). After 5 min incubation on ice, cells were 
pulsed at 2.5 kV (Micro-Pulser, Bio-Rad), and then immediately resuspended in 700 µl pre-
warmed SOC medium. Cells were incubated for at least 1 h at 37 °C under constant 
shaking at 750 rpm in a thermo mixer (Qiagen) and finally plated onto selective LB plates 
and incubated over night at 37 °C. 
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2.2.2 Preparation and transformation of competent S. cerevisiae cells 
Chemical competent S. cerevisiae cells were prepared from 50 ml YPD cultures, which 
were inoculated with an over-night pre-culture to an OD600 of 0.2 and grown to an OD600 
of 0.8-1.0. After the cells reached their final OD600, they were centrifuged at 1800 g, 
washed with sterile water, centrifuged again, washed with 1ml Li-Acetate [100 mM], 
centrifuged and the pellet was finally resuspended in 500 µl Li-Acetate [100 mM]. 50 µl 
aliquots were prepared, centrifuged again and the supernatant was discarded. Competent 
cells were used directly for highest competence or stored at -20 °C for a few days. For 
transformation 240 µl PEG 3350 were added, followed by 50 µl salmon sperm DNA and 
36 µl 1M Li-Acetate. 1000 ng digested vector and 600 ng Insert, or 500 ng plasmid were 
added, in a total volume of 34 µl. Samples were mixed vigorously by pipetting or vortexing 
and then incubated at 30 °C for 30 min, followed by a heat shock at 42 °C for 25 min. 
Finally cells were centrifuged for 15 s, resuspended in sterile water and plated on selective 
plates. 
To prepare chemical competent S. cerevisiae cells for genomic recombination, 50 ml YPD 
cultures were grown as described above but to an OD600 of 0.5-07. Cells were centrifuged 
at 1800 g, washed with sterile water, centrifuged again and resuspended in 5 ml LitSorb. 
After another centrifugation step the pellet was resuspended in 360 µl LitSorb. 40 µl pre-
heated Salmon sperm DNA were added, and after mixing 50 µl aliquots were prepared 
and used directly. For transformation 10 µl of PCR product and 360 µl LitPEG were added 
to 50 µl of competent cells, followed by incubation at room temperature (RT) for 30 min. 
Then 47 µl DMSO were added and the cells were incubated at 42 °C for 15 min. Finally, 
cells were centrifuged at 1500 g for 3 min, the pellet was resuspended in 200 µl sterile 
water and plated on selective plates. 
 
2.2.3 Cloning and mutagenesis 
Primers for Polymerase Chain Reaction (PCR) were designed to have a melting 
temperature close to 55 °C, with primer pairs used in one reaction having the same 
melting temperature. Primers used for classical cloning had a 5’-overhang of several 
nucleotides before the restriction site to facilitate restriction cleavage. Complementary 
regions consisted of at least 18 bp. Primers for site-directed mutagenesis via Quick-
Change, comprised at least 15 bp of complementary sequences harboring the mutation on 
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each side. PCR reactions were carried out using either Herculase II (Stratagene), Phusion 
Polymerase (Finnzymes) or Taq polymerase (Fermentas), depending on requirements. 
Reactions were carried out in 50 µl sample volume, containing polymerase specific 
buffers, 10-50 ng of plasmid DNA or 100-200 ng genomic DNA, 0.2 mM dNTP-mix, 0.5 µM 
of each, forward and reverse primer, 0.5 µl Polymerase (2-5U) and optionally MgCl2, if not 
included in the polymerase buffer. Quality of PCR products was usually controlled via 
agarose gel electrophoresis (1 % w/v), bands were visualized with SYBR-Safe DNA gel stain 
(1:10000, Invitrogen), and the desired bands were purified using a gel extraction kit 
(Qiagen). If no quality control was required, PCR products were directly purified using a 
PCR purification kit (Qiagen). 
Purification tags were either introduced via encoding in the primer, or alternatively by in 
frame cloning into the vector. Vectors from the pET series, used for E. coli cloning, were 
obtained from Novagen. For S. cerevisiae cloning the pRS series from Euroscarf was used. 
PCR Products and vectors were digested using restriction endonucleases obtained from 
NEB or Fermentas. Digested vectors were dephosphorylated prior to ligation reactions 
using an Alkaline Phosphatase (NEB or Fermentas), which was then inactivated by 
incubation at 80 °C for 20 min, followed by purification via agarose gel electrophoresis. 
Concentrations of PCR products and linearized vectors were determined using a ND-1000 
(NanoDrop) spectrophotometer, via the absorption at 260 nm. Different molar ratios of 
Vector to PCR product, usually 1:5 and 1:2, were used for ligation. Ligation reactions were 
carried out using a T4 DNA ligase (NEB or Fermentas) with the provided buffer in 20 µl 
reaction volume. Ligation reactions were incubated for 3-4 h at RT, or over night at 16 °C. 
Transformation was performed as described in 2.2.1. 
For cloning via homologous recombination, primer pairs were designed, harboring a 40 bp 
sequence, complementary to the borders of the multiple cloning site of the plasmid. PCR 
products were synthesized and purified as described above. The plasmid was digested 
with one or two different restriction enzymes, that cut only at the multiple cloning site 
and was purified as described above. Then competent yeast cells were transformed with 
digested plasmid and PCR product as described in section 2.2.2. 
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2.2.4 Protein expression in E. coli 
Recombinant proteins were expressed in E. coli BL21 (DE3) RIL cells (Stratagene). Cells 
were transformed with plasmids carrying the desired protein as described in 2.2.1. For 
induction with IPTG, cells were grown in LB media including the required antibiotics at 
37 °C to an OD600 of 0.6, cooled down on ice to 18 °C, followed by addition of IPTG to a 
final concentration of 1 mM. Cultures were then further grown over night at 18 °C.  
For autoinduction, cells were grown in TB media with antibiotics and the additive 5052 
(Table 10). Cells were grown to an OD600 of 0.5 at 37 °C, then cooled down to 24 °C and 
grown over night at this temperature. Cells were harvested by centrifugation at 3500 g at 
4 °C for 20 min, washed with PBS and flash frozen in liquid nitrogen before they were 
stored at -80 °C. 
 
2.2.5 purification of recombinant Rrn3 
Proteins from S. cerevisiae were cloned and expressed as described in 2.2.3 and 2.2.4. Cell 
pellets were thawed and lysed by sonification. The lysate was centrifuged and the 
supernatant was loaded onto a 1 ml gravity flow Ni-NTA (QIAGEN) column equilibrated in 
Ni-NTA lysis buffer. The column was washed with 20 column volumes (CV) Ni-NTA wash 
buffer containing 20 mM imidazol, followed by washing steps with buffer A containing 
30 mM and 50 mM imidazol. Protein was eluted with buffer A containing 150 mM 
imidazol.  
Proteins carrying a Strep-Tag were bound to a 1 ml Strep-Tactin Separose column (IBA) 
equilibrated in buffer A and eluted with buffer A containing 2.5 mM d-Desthiobiotin. 
Elution fractions were analysed via SDS PAGE and fractions containing the desired protein 
in an appropriate purity were pooled. Proteins were further purified by anion exchange 
chromatography (Mono Q, GE Healthcare). The column was equilibrated in 90% buffer A 
and 10 % buffer B (100 mM NaCl) and proteins were eluted with a linear gradient of 20 CV 
from 100 mM to 1 M NaCl. After concentration, the sample was applied to a Superdex 200 
size exclusion chromatography column (GE Healthcare) equilibrated with buffer C. Pooled 
peak fractions were concentrated to 10 mg/ml or higher. 
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2.2.6 Protein analysis 
Determination of protein concentrations 
Protein concentrations of crude protein solutions before purification were usually 
determined using the Bradford assay (Bradford, 1976). 1-10 µl of Protein solution were 
added to 1 ml of diluted (1:5 with ddH2O) Bradford reagent solution (Bio-Rad), and the 
absorption at 595 nm was measured. Protein concentrations were then calculated from a 
reference curve that was previously prepared using bovine serum albumin as a standard 
(Fraktion V, Roth). 
Protein concentrations after purification were determined by measuring the absorption at 
280 nm using and ND-1000 (NanoDrop) spectrophotometer and calculated with the molar 
absorption coefficients calculated with ProtParam based on the Protein sequence (ExPASy, 
Bioinformatics resource portal). 
 
SDS-Polyacrylamid gel electrophoresis 
Proteins were usually analysed after electrophoretic separation via an SDS PAGE in a Bio-
RAD gel system with acrylamide/bisacrylamide gels. For better resolution commercially 
available NuPAGE Novex Midi-Bis-Tris 4-12% gradient gels (Invitrogen) were used 
according to the manufacturer’s instructions. Gels were stained with Coomassie solution 
for 15 min and destained over night in destaining solution (Table 12). 
 
Limited proteolysis analyses 
To determine stable and compactly folded domains of the protein for crystallization trials, 
a limited proteolysis was performed applying three different proteases, Trypsin, 
Chymotrypsin and Subtilisin. 120 µl protein solution (1 µg/µl) were incubated with each 
1 µl of the first two proteases (1 µg/µl) and reactions were stopped by heat-inactivation 
after 1, 2, 10, 30 and 60 min. A 1 µg/µl solution of Subtilisin was diluted 1:10, 1:100 and 
1:1000 respectively, and 1 µl of each dilution was incubated with 20 µl of protein solution 
(1 µg/µl) on ice for 1 h and heat-inactivated afterwards. The samples were mixed with SDS 
sample buffer and degraded Protein fragments were separated via SDS-PAGE. Bands were 
excised from the gel and analysed via EDMAN sequencing (Niall, 1973). 
 
 
 
40 
 
 2 Materials and Methods 
 
Edman sequencing 
Protein Bands excised from a coomassie stained SDS gel were transferred onto a PVDF 
membrane by passive adsorption. Therefore gel-bands were dried in a speed-vac 
centrifuge, rehydrated in 20 µl swelling buffer at room temperature. A concentration 
gradient was set up by adding 100 µl ddH2O and a small piece of an ethanol-soaked PVDF 
membrane (Schleicher & Schuell) was added. After the solution turned blue, 10 µl 
methanol were added as a catalyst and the mixture was incubated for 2-4 days until the 
transfer was complete. The membrane was washed 5 times in 10 % methanol and The 
protein was N-terminally sequenced from the dry membrane in a PROCISE 491 sequencer 
(Applied Biosystems). 
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2.3 Rrn3 Crystallization and characterization 
2.3.1 Crystallization screening 
For crystallization of Rrn3, pure protein was concentrated to 10 mg/ml. Initial 
crystallization screens in microplates with 200 nl sitting-drops were performed at the 
Crystallization Facility at the MPI of Biochemistry, Martinsried. Scale-up of initial 
crystallization conditions was done in 2 µl hanging drops over 500 µl reservoir solution, 
resulting in a final crystallization condition containing 14% PEG 3350 and 250 mM sodium-
potassium-tartrate. 
 
2.3.2 Crystal structure determination 
Directly after harvesting crystals from the drop, they were cryo-protected by a stepwise 
transfer to reservoir solutions containing 5-20% PEG 200, and finally flash-frozen in liquid 
nitrogen. For structure determination crystals were soaked in a reservoir solution 
containing 10 mM Thiomersal for 2-12 min, depending on crystal shape and size and 
subsequently transferred to the solutions additionally containing the cryo-protectant, and 
finally flash frozen in liquid nitrogen. Diffraction data were obtained on a PILATUS 6M 
detector at the Swiss Light Source in Villigen, Switzerland and processed with XDS (Kabsch, 
2010) (Table 16). With SHELXD (Schneider and Sheldrick, 2002) two mercury sites were 
detected. SHARP (Bricogne et al, 2003) was used for MAD phasing. Initial model building 
was performed with Buccaneer (Cowtan, 2006), and further building of the final structure 
was done with COOT (Emsley and Cowtan, 2004). Refinement was carried out using 
PHENIX (Terwilliger et al, 2008) and BUSTER (Blanc et al, 2004). The structures and 
diffraction data of Rrn3 have been deposited in the Protein Data Bank under accession 
code 3TJ1.  
 
2.3.3 Small angle X-ray scattering 
Rrn3 was purified as described in 2.2.5 and finally concentrated to 2 or 8 mg/ml in 
buffer C. The flow-through of the concentration step was used as buffer reference for the 
SAXS measurements. SAXS data were collected at beam line X33 at EMBL/DESY, Hamburg. 
BSA and lysozyme were measured as reference for molecular mass determination from Io, 
which was obtained from extrapolation of s→0 in Guinier-analysis with s*Rg <1.3 (Putnam 
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et al, 2007). Data analysis was done using the ATSAS package (Konarev et al, 2006). 
Theoretical scattering profiles from the known Rrn3 monomer or dimer structure were 
calculated and fitted to the measured profile with CRYSOL. Ab initio modeling from the 
experimental data was performed with DAMMIF and GASBOR without imposing symmetry 
or other restrictions. Models were aligned, filtered and averaged with SUPCOMB and 
DAMAVER (Volkov and Svergun, 2003). Envelope representations were calculated with 
SITUS (Wriggers and Chacon, 2001).  
 
2.3.4 Static light scattering analysis 
A size exclusion chromatography column (Superose 6 10/300 or Superdex 200 GE 
Healthcare) was connected to a triple detector TDA (Viscotek). The system was 
equilibrated and standardized with a BSA protein sample. Gel filtration runs were 
performed with Pol I-Rrn3 complex and, for direct comparison with Pol I alone on a 
Superose 6 column. Samples typically contained 100 µg Pol I. Rrn3 samples were tested 
for dimerization on a Superdex 200, using typically 200 µg Rrn3 in a sample. Wild-type 
Rrn3 (WT) was compared to mutants R452G, D405A and S444/448D and E398A. Data 
analysis was done with the OmniSEC software (Viscotek). 
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2.4 RNA Polymerase I-Rrn3 complex preparation and characterization  
2.4.1 Purification of endogenous RNA Polymerase I 
S. cerevisiae strain GPY2 (ade2-101, trp1-Δ63, ura3-52, his3-Δ200, lys2-801, leu2::RPA43), 
carrying a pAS22 plasmid coding for a HA- and hexahistidine tagged version of A43, was 
cultivated in a 200 l fermenter. Cells were harvested at an OD600 of 5-9 by flow-through 
centrifugation, yielding a 2-2.5 kg cell pellet. 1 kg cells were resuspended in 500 ml 
freezing buffer, and flash-frozen in liquid nitrogen in batches of 225 ml, two of these 
batches were used for one Pol I purification. Fermentation and harvesting of cells was 
done by Stefan Benkert. 
Cells were slowly thawed, then Ammonium Sulfate was added to a final concentration of 
400 mM, together with Protease Inhibitors and DTT (5 mM). Phosphatase inhibitors were 
added as listed in table 15. For lysis, resuspended cells were filled into bead beaters 
(BioSpec Products) and 200 ml glass beads (0.5 mm, BioSpec Products) were added. To 
prevent foam formation the bead beater was filled up to the edge with dilution buffer and 
air bubbles were removed by stirring with a glass rod. Lysis was carried out in the cold 
room at 4 °C for 90 min in repetitive cycles of 30 s bead-beating followed by 90 s cooling. 
The bead beaters were additionally cooled with a mixture of ice and salt. 
The lysate was then separated from the beads by filtration and centrifuged for 30 min at 
75000 g (Sorvall SLA 1500), followed by ultra-centrifugation for 90 min at 30000 g 
(Beckmann SW28). The top fat layer was aspirated and the clear supernatant was 
separated from the pellet and dialysed over night at 4 °C against dialysis Buffer. The 
dialysed extract was centrifuged for 60 min at 18500 g (Beckmann Ti45). The supernatant 
was discarded and the resulting pellet was resuspended in Res/W1 buffer yielding a final 
volume of 50 ml. The sample was then split into two 25 ml batches and incubated on a 
turning wheel for 4 h at 4 °C with each 4 ml Ni-NTA resin (Qiagen), which was previously 
equilibrated in Res/W1 buffer. The resin was then loaded into two gravity-flow columns 
and washed with 5 CV Res/W1 buffer, followed by 5 CV W2 buffer, and finally eluted with 
25 ml E1 buffer each. The eluate was pooled and subjected subsequently to an anion 
exchange chromatography (MonoQ 10/100, GE Healthcare). The column was equilibrated 
in 15 % MonoQ buffer B, and the sample was eluted in a multi-step gradient. Pol I 
fractions eluting at 1100 mM KoAc were pooled and diluted to a final concentration of 
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200 mM KoAc. Proteins were further purified via cation exchange chromatography 
(MonoS 5/50, GE Healthcare), using the MonoQ buffers A and B applying a gradient from 
200 mM to 2 M KoAc. Pol I eluted at 500 mM KoAc, fractions were pooled, concentrated 
and further purified via Gel filtration chromatography (Superose 6 10/300, GE Healthcare).  
 
2.4.2 Assembly of the RNA Polymerase I-Rrn3 complex 
Pol I was purified as described in 2.4.1 with all buffers containing Phosphatase inhibitors 
(Table 15) and concentrated to 1 µg/µl. Rrn3 was purified as described in 2.2.5 and 
concentrated to 20 µg/µl. For assembly of the Pol I-Rrn3 complex, Pol I was incubated 
with a 9-fold molar excess of Rrn3 on ice over night, followed by size exclusion 
chromatography and concentration of the fractions containing the complex. 
 
2.4.3 Native Mass-Spectrometry analysis 
For native MS the sample buffer was exchanged to a solution containing 200 mM 
ammonium acetate using centrifugal filter units (Millipore) and sample concentration was 
adjusted to 2 µM. MS was carried out on a Q-ToF I instrument (Geiger et al, 2010; van den 
Heuvel et al, 2006). The cone voltage was 150 V and the needle voltage was 1.3 kV. The 
pressure in the source region was 10 mbar. Xenon was used as a collision gas with a 
pressure of 2 x 10-2 mbar (Lorenzen et al, 2007). Data were analyzed with MassLynx 
(Waters).  
 
2.4.4 Protein crosslinking and Mass Spectrometry 
Pol I was purified as described in 2.4.1 except that size exclusion chromatography 
(Superose 6 10/300, GE Healthcare) was performed in a buffer containing 20 mM HEPES at 
pH 7.8, 300 mM potassium acetate (KoAc), 1 mM MgCl2, 10 % glycerol and 5 mM DTT. 
Pol I fractions were pooled and concentrated to 1 mg/ml and preparation of the Pol I-Rrn3 
complex was done as described in 2.4.2. The complex was cross-linked using isotopically 
coded disuccinimidyl suberate (DSS-H12/D12, Creative Molecules Inc.). The purified Pol I-
Rrn3 complex (100 µl containing 110 µg) was mixed with 25 mM DSS stock solution 
dissolved in dimethylformamide (DMF, Pierce Protein Research Products) to a final 
crosslinker concentration of 0.6 mM, 0.9 mM, 1.2 mM, 1.5 mM and 2 mM, respectively, to 
screen for the ideal crosslinking conditions. The result was analysed on an SDS-PAGE to 
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detect crosslinked proteins. The best crosslinker concentration, 1.2 mM, was sufficient to 
convert the free Rrn3 band and most of the individual Pol I subunits to a higher molecular 
weight band but still avoiding formation of oligomers of the complex. For the final 
reaction 110 µg Pol I was mixed with DSS to a concentration of 1.2 mM as described for 
the test-crosslinking reactions, and incubated for 30 min at 30 °C and 350 rpm. The 
reaction was stopped by addition of NH4HCO3 to a final concentration of 100 mM and 
incubation at 30 °C for 15 min. Cross-linked proteins were treated with two sample 
volumes of 8 M urea and reduced and alkylated using 5 mM Tris(2-
carboxyethyl)phosphine (TCEP) and 10 mM iodoacetamide, respectively. The sample was 
digested with trypsin. MS analysis was performed as described (Leitner et al, 2010). The 
fragment ion spectra were finally assigned to crosslinked peptides using the software 
xQuest (Rinner et al, 2008). 
 
2.4.5 Purification of recombinant A43/14 
Plasmid pET21b (Novagen), carrying the genes for A14 and A43 with a Hexahistidine Tag 
encoded on the C-terminus of subunit A43, was used for expression of the Pol I 
subcomplex A14/43 in E. coli. Expression and lysis of cells was done as described in 2.2.4 
and 2.2.5. After centrifugation the lysate was loaded onto a 2 ml Ni-NTA column pre-
equilibrated in buffer L2. The column was washed with 5 CV buffer A2, then Proteins were 
eluted with buffer L2 containing 150 mM imidazol. Eluted fractions were diluted with 
buffer A2, to a final NaCl concentration of 100 mM. The sample was then subjected to an 
anion exchange chromatography (MonoQ 10/100 GE Healthcare). The column was pre-
equilibrated with 10 % buffer B2, and proteins were eluted with a linear gradient from 100 
mM to 1M NaCl. The heterodimer A14/43 eluted at 220 mM NaCl. After concentration, 
the sample was applied to a gel filtration chromatography (Superose 12 HR 10/300, GE 
Healthcare) equilibrated with buffer C2. Peak fractions were pooled and concentrated to 
10 µg/µl. 
 
2.4.6 Protein interaction analysis  
Rrn3 carrying an N-terminal Strep-Tag was incubated with the A43/14 subcomplex, 
carrying a C-terminal Hexahistidine Tag on subunit A43, in different molar ratios. A43 was 
either the wild-type Protein or different S→D variants, mimicking a permanent 
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phosphorylation. A43 variants were produced by site directed mutagenesis as described in 
2.2.3. Proteins were incubated on ice for 30 min and then loaded onto a Ni-NTA gravity-
flow column, washed with L2 and then L2 containing 60 mM Imidazol, and eluted with L2 
containing 150 mM Imidazol. Eluted fractions were concentrated or subjected to a TCA 
precipitation and analysed via SDS-PAGE. 
 
2.4.7 Cryo-EM data collection and processing 
A solution of purified Pol I-Rrn3 complex was diluted to ≤ 0.1 mg/ml using Pol I Superose 6 
buffer and applied to glow-discharged pre-coated carbon holey grids (Quantifoil R3/3, 
2nm carbon on top). For negative-stain, samples were treated with 2% uranyl acetate on 
the grid and subsequently dried at room temperature. Samples for Cryo EM were flash-
frozen in liquid ethane using a semi-automated controlled environment system (Vitrobot, 
FEI Company) at 4° C, that keeps constant 95% humidity, and stored in liquid nitrogen until 
transfer to the microscope. Micrographs were recorded under low dose conditions of ~15 
electrons/Å2 on a FEI Tecnai Spirit microscope operating at 120 kV, equipped with a LaB6 
filament and a Gatan side entry cryo-holder. Image collection was done at seven different 
under focus values in the range of 1.5-4 μm on a 2k x 2k FEI Eagle CCD camera with a pre-
exposure of 100 ms at a magnification of 90.000x which resulted in a pixel size of 
3.31 Å/px on the object scale. Initial particle selection and windowing was performed 
semi-automatically using the boxer program from the EMAN2 software package (Tang et 
al, 2007). Reference particles were picked manually on every micrograph to avoid 
discrepancies due to defocus and ice differences and the resulting automatically selected 
particles were verified visually. Windowed particles were aligned to 83 projections of the 
Pol II X-ray structure (1Y1W, Gaussian low-pass filtered to 35 Å), which was modified by 
removing the OB and HRDC domains from subcomplex Rpb4/7 since they show high 
conformational flexibility and the HRDC domain is absent in the Pol I subcomplex A43/14. 
EMAN2 output files were reformatted to SPIDER stack files and further processing was 
carried out using the SPIDER software package (Frank et al, 1996). Backprojection of the 
particle images using the angles from reference-based alignment resulted in a first 
reconstruction, further used as reference for 20 rounds of angular refinement. Images 
were back-projected in real space using the refined angles. The final  reconstruction from 
11503 particles was Gaussian low-pass filtered to 25 Å. 
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2.5 Yeast genetics and assays 
2.5.1 Sporulation and Tetrad dissection 
The diploid strain Y24975 (BY4743; Mat a/a; his3D1/his3D1; leu2D0/leu2D0; lys2D0/LYS2; 
MET15/met15D0; ura3D0/ura3D0; YKL125w::kanMX4/YKL125w) (Euroscarf) was first 
transformed with plasmid pRS316, containing the URA3 gene and carrying a copy of wild-
type Rrn3 under a native promoter, as described in 2.2.2. For Sporulation cells were 
streaked out on pre-sporulation plates, and after incubation at 30 °C for 2 days, a few 
colonies grew on the plates and were restreaked onto sporulation plates, followed by 
another incubation for at least 3 days. For tetrad dissection, spores were treated with 
glusulase (Perkin Elmer) and then separated with a micromanipulator needle and 
deposited in distinct positions on a YPD plate. Clones were selected that carried a kanMX4 
cassette replacing Rrn3 in the haploid genome, by streaking out on plates containing 
G-418 (Geneticin). The resulting strains necessarily carry the pRS316 plasmid with a copy 
of Rrn3-WT under a native promoter. Nevertheless they were tested by streaking out 
clones that were positive for the kanMX4 cassette on –Ura selective plates, before further 
use for complementation assays. 
 
2.5.2 long-term storage of yeast strains 
The respective strain was cultivated in YPD media over night, then 750 µl were mixed in a 
1.5 ml reaction tube with glycerol to a final concentration of 30 % glycerol and then stored 
at -80°C. For further use one glycerol-stock was thawed and streaked out on a YPD plate, 
or diluted in 25 ml YPD media and grown over night at 30 °C. 
 
2.5.3 Mating type determination 
To define the mating type of the resulting strains after tetrad dissection a colony-PCR 
reaction was performed using three primers (oligo 1: agtcacatcaagatcgtttatgg, oligo 2: 
cacggaatatgggacta-cttcg, oligo 3: actccacttcaagtaagagtttg) simultaneously. A specific 
pattern of resulting PCR products was analysed on an agarose gel and verified either 
mating type a or α. 
 
 
48 
 
 2 Materials and Methods 
2.5.4 Gene disruption and epitope tagging 
To place genetically encoded purification Tags onto proteins of interest, S. cerevisiae cells 
were transformed as described in 2.2.2 with PCR products containing the desired tag, a 
selection marker and overlapping sequences, allowing for homologous recombination as 
described (Janke et al, 2004). Transformants that grew on selective plates were picked and 
streaked out again on YPD or selective plates, for further selection and to get more 
material, and were then tested for successful integration of the cassette by colony PCR 
and in some cases DNA sequencing of the resulting product. Successful expression of 
tagged proteins was proved via Western Blot with antibodies directed against the 
respective tag. 
 
2.5.5 quantitative western blot analysis 
To determine relative expression levels of TAP tagged Rrn3 variants or tagged Pol I 
subunits an alkaline lysis was performed and protein expression levels were analysed via 
western blot. A small amount of cells was collected from a plate with an inoculation loop, 
resuspended in 1 ml water, mixed with 150 µl alkaline lysis solution and incubated for 
15 min on ice. Then 150 µl 55 % TCA were added, followed by incubation on ice for 
10 min. Cells were centrifuged at 3500 g for 15 min at 4 °C, the supernatant was discarded 
and the pellet resuspended in 50 µl sample buffer, neutralized with ammonia and boiled 
for 5 min at 95 °C. 5 µl sample was then loaded onto an SDS gel. The gel was subsequently 
blotted onto a nitrocellulose membrane for 1 h at 100 V under constant cooling in the cold 
room (4 °C). The membrane was blocked for 1 h with PBS containing 2 % (w/v) milk 
powder. Then the membrane was cut into two pieces below the 70 kDa marker band. The 
upper part was incubated with an antibody against the TAP tag (PAP, Sigma), and the 
lower part with an antibody against tubulin (3H3087, Santa Cruz Biotechnology, rat). All 
antibodies were dissolved in 10 ml PBS containing 2 % (w/v) milk powder and incubated 
with the membrane for 1 h. After washing with PBS containing 0.1 % Tween, the lower 
part of the membrane was incubated with horseradish-peroxidase (HRP) coupled anti-rat 
antibody (Jackson ImmunoResearch) for one hour and washed again. Antibodies were 
detected by chemoluminescence (ECL Plus Western Blotting detection system, GE 
Healthcare). Detection was carried out with the LAS3000 detection system (Fuji) after 
incubation with the ECL Plus western blotting detection agent (GE Healthcare). Signals 
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were quantified in relation to the tubulin loading control using the ImageQuant TL 7.0 
Image Analysis Software (GE Healthcare). 
 
2.5.6 Complementation and phenotyping assays 
A yeast shuffle strain was generated as described in 2.5.1. The strain was then 
transformed as described in 2.2.2 with plasmids carrying a LEU2 marker and the wild-type 
gene or mutants of the gene of interest or, as a control, empty plasmid. Transformants, 
that grew on selective plates were streaked out on -LEU plates repeatedly to lose the 
pRS316 rescue plasmid carrying wt Rrn3 as no selection for the URA3 marker is given 
anymore. Finally a small amount of cells was collected from the plate, washed in ddH2O, 
set to an OD600 of 1.0 in water, and spotted in serial dilution onto 5-FOA plates or YPD 
plates to test if the protein variants could complement the loss of the rescue plasmid. 
Growth on 5-FOA plates is only possible after loss of the rescue plasmid carrying the wt 
rrn3 gene and the URA3 marker, that encodes orotidine 5-phosphate decarboxylase 
(ODCase), which converts 5-FOA into the toxic compound 5-fluorouracil. Consequently, 
growth of the resulting strain is only observed if at least partial complementation by the 
protein variant expressed from the new rescue plasmid is possible. To further characterize 
the phenotype, a small amount of cells was collected from the 5-FOA plates, washed 
again, set to an OD600 of 1.0 in water, and spotted in serial dilution onto YPD plates 
containing either 0.025 µg/ml Rapamycin, or 0.25 µg/ml Cycloheximide.  
For growth curves, 50 ml YPD cultures were inoculated to an OD600 of 0.1 with an 
overnight culture of a strain carrying either plasmid pRS315 expressing wt Rrn3 or an Rrn3 
variant. Measurements of OD600 were conducted every hour until an OD600 of 0.8-1.0 was 
reached. 
 
2.5.7 Chromatin Immunoprecipitation (ChIP) analysis 
S. cerevisiae shuffle strain, derived from Y24975 (Euroscarf) and carrying wt or mutant 
rrn3 on a rescue plasmid with or without TAP tag, as described in 2.5.6, was grown in 
50 ml YPD medium and at 30 °C to mid-log phase (OD600 ~ 0.8). Cells were treated with 
formaldehyde (1%, Sigma F1635) for 20 min at 20°C, and cross-linking was quenched with 
5 ml of 3 M glycine for 10 min. Subsequent steps were performed at 4°C with pre-cooled 
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buffers containing protease inhibitors (1 mM Leupeptin, 2 mM Pepstatin A, 100 mM 
Phenylmethylsulfonyl fluoride, 280 mM Benzamidine). Cells were collected by 
centrifugation, washed twice with 1xTBS (20 mM Tris-HCl at pH 7.5, 150 mM NaCl), and 
twice with FA lysis buffer (50 mM Hepes-KOH pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% triton 
X-100, 0.1% sodium deoxycholate, 0.1% SDS). Pellets were flash-frozen in liquid nitrogen 
and stored at -80°C. Pellets were thawed, resuspended in 1 ml FA lysis buffer, and 
disrupted by bead beating (Retsch) in the presence of 1 ml silica-zirconia beads for 30 min 
at 4 °C. Chromatin was solubilized and fragmented via sonification with a BioruptorTM 
UCD-200 (Diagenode Inc.). 700 µl sample was immuno-precipitated with 20 µl IgG 
SepharoseTM 6 Fast Flow beads (GE Healthcare) at 4 °C for 1 h. Immuno-precipitated 
chromatin was washed three times with FA lysis buffer, twice with FA lysis buffer 
containing 500 mM NaCl, twice with ChIP wash buffer and once with TE buffer. Immuno-
precipitated chromatin was eluted for 10 min at 65 °C with ChIP elution buffer, digested 
with proteinase K (Sigma) at 37 °C for 2 h, and crosslinks were reversed at 65 °C over-
night. DNA was purified with the QIAquick PCR Purification Kit (Qiagen). Input and 
immuno-precipitated samples were assayed by qPCR using primer pairs directed against 
different regions of the first repeat within the RDN1 locus. PCR reactions contained 1 µl 
DNA template, 2 µl of 10 µM primer pairs and 12.5 µl iTaq SYBR Green Supermix (Bio-Rad). 
qPCR was performed on a Bio-Rad CFX96 Real-Time System (Bio-Rad Laboratories, Inc.) 
using a 3 min denaturing step at 95°C, followed by 49 cycles of 30 s at 95°C, 30 s at 61°C 
and 15 s at 72 °C. Threshold cycle (Ct) values were determined by application of the 
corresponding Bio-Rad CFX Manager software version 1.1 using the Ct determination 
mode “Regression”. Fold enrichment of any given region over a non-transcribed 
heterochromatic region on chromosome V was determined as described (Fan et al, 2008).  
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2.6 Bioinformatic tools 
Protein and gene sequences were obtained from the NCBI 
(http://www.ncbi.nlm.nih.gov/), uniprot (http://www.uniprot.org/) or the Saccharomyces 
cerevisiae genome database (http://www.yeastgenome.org/). Bioinformatic analysis were 
performed mostly using the Bioinformatics Toolkit (Biegert et al, 2006). Multiple sequence 
alignments were done with ClustalW (Chenna et al, 2003) or MUSCLE (Edgar, 2004) and 
displayed with ESpript (Gouet et al, 1999). Secondary structures were predicted with 
PredictProtein (Rost et al, 2004) or using the Bioinformatics Toolkit (Biegert et al, 2006). 
Molar absorption coefficients were calculated with ProtParam based on the Protein 
sequence (ExPASy, Bioinformatics resource portal) (Gasteiger et al, 2003). HHpred (Soding 
et al, 2005) was used for homology detection and structure prediction of Rrn7. Structures 
were modeled with Modeller (Eswar et al, 2008), from the online source 
(http://toolkit.tuebingen.mpg.de/modeller)   
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3 Results  
 
3.1 Structural characterization of the RNA Polymerase I transcription 
initiation factor Rrn3 
3.1.1 Rrn3 crystallization 
Rrn3, the central transcription initiation factor of the RNA Polymerase I transcription 
system, is essential for efficient recruitment of the Polymerase to the pre-Initiation 
complex and subsequent transcription initiation. Rrn3 initially forms a stable complex with 
Pol I prior to recruitment of the whole complex to the promoter. To extend our knowledge 
on the function of this factor and to better understand the interplay of Rrn3 with Pol I we 
attempted to solve the structure of this cenral factor. Rrn3 was expressed recombinantly 
from E. coli and a purification protocol was established using auto-inductive TB medium 
for protein expression, that yielded 2-3 mg of pure protein from an 8 l culture (Methods 
2.2.3-2.2.5). The purified protein was subjected to limited proteolysis and subsequent 
EDMAN sequencing (Methods 2.2.6), which revealed stable fragments lacking the N-
terminal 33 or 47 aminoacids. Mass-spectrometry analysis of the protein combined with 
the results obtained from EDMAN sequencing and secondary structure predictions 
revealed a flexible loop between positions V242 and Q323 and a flexible C-terminal 
region, starting from position E545. Thus, a stable N-teminal and a stable C-terminal 
domain were predicted and constructs were designed and cloned accordingly. The wild-
type protein (WT), a variant lacking the first 33 aminoacids (ΔN), a construct lacking the 
flexile N- and C-terminal regions (ΔNΔC) and a construct lacking the middle loop (ΔL), as 
well as the N- and C-terminal domains (N-term, C-term), were expressed in E. coli. Only 
the wild-type protein and the ΔN variant were expressed properly and were soluble under 
the established conditions. After purification the protein was concentrated to 10 mg/ml in 
gelfiltration buffer and subjected to initial screens in sitting-drop 96 well crystallization 
plates either by an in-house crystallization-robot or at the crystallization facility at the MPI 
of Biochemistry, Martinsried. Several initial and promising hits were obtained from a 
range of different screens (examples are depicted in Figure 4). As the initial crystals of the 
wt protein seemed to be the same or better quality than for the ΔN construct, the full 
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length protein was used for scale-up of the crystal conditions to 2 µl hanging drops and 
optimization to get a crystal size and shape suitable for data collection. Scale-up led to 
large but very thin crystal plates (50 x 300 µm), which were mostly adhered and crooked 
and resulted in high mosaicity and bad quality diffraction data. This problem could be 
overcome by microseeding in the crystallization drops, further refinement of the 
crystallization condition and an improved protocol for cryo cooling protection (Figure 5). 
Diffraction data up to 2.8 Å could be collected for a native crystal (Table 16).  
As expression of the protein in minimal media was poor, selenomethionine derivatisation 
was not successful and therefore phasing of the crystals had to be accomplished through 
soaking with heavy metal derivatives. Several compounds were tested for derivatisation of 
crystals through co-crystallisation or soaking. Finally, a soak with 10 mM Thiomersal for a 
few minutes, fine-tuning of the incubation time in function of crystal size and shape, 
proved to be successful. Two mercury sites could be detected and the structure was 
determined by multiple wavelength anomalous diffraction (MAD) at 2.8 Å resolution 
(Table 16). 
 
 
Figure 4.  Initial Crystallization Hits 
Upper lane: crystallization in-house robot, 96 well plate 200 µl sitting drops. Screen: Hampton Peg/Ions and 
Hampton Natrix. Lower lane: crystallization screen at MPI facility, 96 well plate, 100 µl sitting drops. 
Different screens. Con-ditions indicated below images. 
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Table 16 Data collection and refinement statistics for Rrn3 
Crystal  Mercury derivative  Native 
 Peak Inflection Remote  
Data collection     
Space group P212121 P212121 P212121 P212121 
Unit cell axes (Å) 94.8/107.8/160.7 94.9/108.2/160.6 94.8/107.9/161.1 96.8/101.8/162.0 
Wavelength (Å) 1.0086 1.0094 1.0129 0.9814 
Resolution (Å) 50-3.0 (3.08–3.0)
1 
50–3.0 (3.08–3.0)
 
50-3.0 (3.08–3.0)
 
50–2.85 (2.92–2.85)
 
Unique reflections 63,653
2
 (4,723)
 
63,104
2
 (4,650)
 
63,345
2
 (4,706)
 
38,054
3
 (2,784)
 
Completeness (%) 100 (100)
 
99.7 (99.7)
 
99.7 (99.9)
 
99.9 (100)
 
Redundancy 3.48  3.46 3.48  9.1 
Mosaicity (°) 0.29 0.25 0.26 0.28 
Rsym (%) 8.8 (56.3)
 
7.9 (46.2)
 
8.1 (56.3)
 
11.0 (65.6)
 
<I/σI> 14.5 (3.45)
 
10.5 (2.6)
 
11.2 (2.32)
 
14.66 (3.83)
 
Refinement  
Number of residues 953 
Number of nonhydrogen atoms 8,075 
Number of solvent molecules  103 
Average B-factor (Å
2
) 62.5 
RMSD bonds (Å) 0.01 
RMSD angles (°) 1.13 
Rcryst (%) 20.8 
Rfree (%) 24.2 
Preferred
4
/Allowed/ Disallowed (%) 96.9/3.1/0.0 
1
 Values in parentheses are for highest resolution shell throughout. 
2
 Friedel pairs not merged 
3
 Friedel pairs merged 
4
 Ramachandran plot statistics from Molprobity 
Figure 5. scale-up and optimization of crystals 
(A) crystals after scale-up, crooked, thin plates. (B) crystals after optimization of conditions and seeding. Final 
crystallization condition: 0.25 M K/Na-Tartrate, 12 % PEG 3350. 
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3.1.2 Rrn3 has a unique HEAT repeat structure 
The structure of full-length Rrn3 encompasses ten HEAT repeats (H1-H10) formed by 20 
pairs of anti-parallel α-helices arranged in a superhelical fold (Figure 6). Three additional 
C-terminal helices, separated by a flexible 25 aminoacid linker (called c-terminal loop in 
Figure 6) after H10,  pack against repeats H6-H10. The term HEAT repeat is an ancronym 
that originates from four cytoplasmic proteins (Huntingtin, elongation factor 3 (EF3), 
protein phosphatase 2A (PP2A), and the yeast PI3-kinase TOR1) all displaying a conserved 
rod-like superhelical fold, but fulfilling broadly distinct functions. HEAT repeat domains are 
known to be involved in protein-protein interactions, and are found in many transport 
proteins (Cingolani et al, 1999; Conti and Kuriyan, 2000), but were never described as part 
of a transcription factor. The superhelical Rrn3 fold is conserved throughout several 
different species, since hydrophobic core residues are conserved between yeast and 
human, as depicted in the alignment in Figure 6. The structure lacks only the 44 N-
terminal residues, which had previously been identified as a flexible tail by limited 
proteolysis and EDMAN sequencing. Furthermore, an acidic loop (residues D253-T322), 
which was also previously predicted to be flexible, the c-terminal loop α20-α21 (residues 
I555-S574) connecting the HEAT repeat fold to the three C-terminal helices, and 11 C-
terminal residues are not resolved in the structure (Figure 6).  
Yeast in vivo complementation assays were performed as described in 2.5.6 to assay the 
impact of deletions of the parts that are not visible in the Rrn3 structure on viability of the 
resulting strain. The results proved that these mobile, less conserved regions are not 
required for essential Rrn3 functions in vivo, since deletion of the acidic loop (ΔL251-320, 
ΔL242-323) or the terminal tails (ΔC617, ΔN (lacking the first 47 aminoacids)) did not result in 
a growth phenotype in yeast (Figure 7). 
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 Figure 6. (A) Alignment and conservation of Rrn3 amino acid sequences of Saccharomyces cerevisiae (S.c.) and 
Homo sapiens (H.s.). Helical secondary structure elements are indicated above the sequences. Pairs of helices 
forming HEAT repeats H1-H10 are indicated as green bars. Disordered regions are labeled with black triangles 
below the alignment. Invariant and conserved residues are highlighted in green and yellow, respectively. 
Hydrophobic core residues are indicated with black bars, and dimer interface residues with orange bars above the 
alignment. Residues forming the ‘serine patch’ are indicated with blue dots above the S.c. sequence. Phosphosites 
mapped in TIF-IA are labeled with red dots below the H.s. sequence. C-terminal helices are in pink. The crosslinked 
lysine K558 is indicated with a purple box. Sequence alignments were done with CLUSTALW2 (Larkin et al, 2007) 
and figures were prepared with ESPript (Gouet et al, 1999). 
(B) Ribbon and cylinder representations of the Rrn3 crystal structure. Secondary structure elements are labeled 
according to (A). The C-terminal helices are highlighted in pink, residues involved in dimerization are in orange. 
Residues forming the conserved serine patch are in blue. The three different views correspond to the standard 
polymerase views front, back, and top, to facilitate comparison with the models shown in Figure 18. This and 
other figures were prepared with PyMol (DeLano Scientific). 
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3.1.3 Rrn3 forms dimers in solution 
During structure determination it became obvious that the asymmetric unit of the Rrn3-
crystals contains a homodimer. Interface residues are depicted in orange in Figure 6. The 
1353.7 Å interface of the homodimer comprises hydrophobic and few polar residues 
(Figure 8) and was predicted to be stable in solution (PISA, www.ebi.ac.uk). To test this, 
we analyzed Rrn3 samples with concentrations of 8 mg/ml and 2 mg/ml by small-angle X-
ray scattering (SAXS) (Figure 8). SAXS analysis revealed a radius of gyration of 4.4 nm, 
which agrees with the calculated radius for the crystallographic dimer (4.2 nm), but not 
with the calculated monomer radius (3.1 nm). Taking into account that the crystal 
structure lacks the first 45 aminoacids, which would add to the radius of the 
crystallographic dimer, the fit with the SAXS calculation would be even more precise. The 
scattering curve also agrees with a theoretical curve calculated from the dimer structure 
(Figure 8A). Also, a SAXS-based ab initio model revealed a shape that resembles the dimer 
(Figure 8B). To test whether dimerization in solution occurs as in the crystals, we mutated 
different interface residues that caused strong ionic interactions or hydrogen bonds in the 
homodimer interface (Figure 6 and 8C). The Rrn3 variants D405A, R452G, and S444/S448D 
were purified and examined by size exclusion chromatography and static light scattering 
Figure 7. Yeast in vivo complementation assays. 
Rrn3 variants were cloned into a pRS315 vector by homologous recombination, transformed into the rrn3 
shuffle strain and spotted in serial dilutions on 5-FOA-containing plates, to shuffle out the Rrn3-expressing 
URA3 plasmid and to test for viability of the resulting strain carrying the plasmid encoding mutant rrn3. 
Plates were incubated at 30 °C for 2-3 days. Results are compared to YPD Plates where normal growth is 
expected. 
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(Viscotec, Figure 8D). This revealed molecular weights (MWs) between 74 and 85 kDa, 
compared to 140-150 kDa for the wild-type dimer (theoretical MW 145 kDa). Thus, Rrn3 
forms a stable homodimer in solution that resembles the dimer in the crystals. 
However, yeast in vivo complementation assays with the respective mutants did not show 
a phenotype, proving that a disruption of the dimer interface has no influence on vital 
Rrn3 function (Figure 8E). 
 
 
 
 
 
 
  
Figure 8. (A) SAXS scattering curve for Rrn3 (light grey) and calculated (Svergun et al, 1995) scattering curves 
for monomeric (black, dotted line) and dimeric Rrn3 (black line). (B) Ab initio SAXS envelope with docked 
Rrn3 homodimer structure. (C) Crystallographic dimer interface. The two views are related by a 180° 
rotation around a vertical axis. Interactions are indicated as dotted lines. Contact distances are within 2.8-
3.5 Å. (D) Size exclusion chromatography shows that Rrn3 mutations S444/S448D, D405A, and R452G disrupt 
the dimer interface and lead to monomerization. The elution profile of wild-type Rrn3 is in black, profiles of 
mutants S444/448D, D405A and R452G are in grey. (E) Monomeric rrn3 mutants were tested for 
complementation of a ΔRrn3 strain and restored growth comparable to WT. 
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3.1.4 The Rrn3 structure exhibits characteristic surface properties 
The Rrn3 surface reveals strongly conserved parts that may be protein binding surfaces as 
they exhibit a rather hydrophobic character (indicated with red circles in Figure 9A). Rrn3 
is involved in many protein-protein interactions as it has been shown to interact with Pol I 
and core factor subunits Rrn6 and Rrn7, in order to recruit the polymerase to the rDNA 
promoter (Miller et al, 2001). 
Surface charges are equally distributed all over the protein except one positively charged 
stretch, which could be involved in nucleic acids binding, although no proof for this could 
be found through preliminary EMSA experiments, suggesting that either a specific 
sequence is required for binding or that this stretch has a different function.  
The dimerization interface observed in the crystal structure displays an overall rather 
hydrophobic character, with some slightly polar residues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 9. (A) Surface conservation. Identical and conserved residues are highlighted in dark and light green, 
respectively. Positions of residues S145 and S185 and the dimer interface are indicated. 
(B) Surface charge distribution. Red, blue, and white areas indicate negative, positive, and neutral charge, 
respectively. 
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3.2 Structural and functional characterization of the RNA Polymerase I-Rrn3 
complex 
3.2.1 Rrn3 binds Pol I as a monomer 
We next investigated whether Rrn3 binds to Pol I as a homodimer or whether the dimer is 
disrupted upon polymerase binding. Endogenous Pol I was purified with the use of a 
hexahistidine tag (2.4.1), and incubated with a nine-fold molar excess of recombinant Rrn3 
carrying a Strep-Tag (2.2.5). The Pol I-Rrn3 complex was separated from excess Rrn3 by Ni-
NTA affinity chromatography and subjected to native mass spectrometry (MS) (Heck, 
2008). This revealed a molecular weight (MW) of 667 kDa (Figure 10), in agreement with a 
Pol I-Rrn3 monomer complex (663 kDa theoretical MW), but not with a Pol I-Rrn3 dimer 
complex (736 kDa).  
 
 
 
 
 
 
 
 
 
 
 
As the A49/34.5 heterodimer is known to dissociate from Pol I (Huet et al, 1976) the 
complex with the molecular weight of 667 kDa could also be explained by a Pol I Δ (Pol I 
lacking A49/34.5) in complex with an Rrn3 dimer, as the molecular masses of the A49/34.5 
Figure 10. Native mass spectrometry reveals that Rrn3 binds Pol I as a monomer. Upper panel: Two 
different charge distributions were detected with masses of 593 and 667 kDa, which refer to Pol I alone 
(or a Pol IΔA49/34.5-Rrn3 complex) and a Pol I-Rrn3 monomer complex, respectively.  
Lower panel: Tandem Mass Spectrometry leads to elimination of subunit A49 from the 667 kDa complex, 
and to elimination of subunits A14, A14.5, and ABC27 from the 593 and the 667 kDa complexes. The 
593 kDa complex additionally eliminates AC40. The remaining Pol I subcomplexes are observed at 
corresponding high mass/charge values. 
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heterodimer (73.5 kDa theoretical MW) and Rrn3 (73.5 kDa theoretical MW including 
Strep-Tag) are almost identical. Dissociation of the 667 kDa complex in the mass 
spectrometer liberated subunit A49, showing that the A49/34.5 heterodimer is present in 
this complex. This leads to the conclusion that monomeric Rrn3 is bound to Pol I. 
Native MS revealed a second complex with a MW of 593 kDa, which can be explained by 
free Pol I (589 kDa theoretical MW) or by a Pol I-Rrn3 complex that lost the A49/34.5 
heterodimer (589 kDa theoretical MW).  
Further, to test the capability of Rrn3 to bind Polymerase as a monomer, the artificial 
monomer variants Rrn3 D405A and R452G were purified and incubated with Pol I to 
establish a complex as described in 2.4.2. Subsequent Gelfiltration separated the complex 
from excess Rrn3, and analysis of the two separated peaks revealed a stable complex of 
the Rrn3 variants with Pol I (Figure 11). These data demonstrate that Rrn3 binds Pol I as a 
monomer, consistent with the results of the yeast in vivo complementation assays that 
proved the viability of a yeast strain expressing an Rrn3 mutant that is incapable of dimer 
formation (Figure 8E).  
 
Moreover, we performed dissociation experiments of the large complex containing Rrn3 
and compared these to dissociation experiments that were performed with Pol I alone. It 
came to our attention that the Pol I-Rrn3 complex shows a different dissociation pattern 
than free Pol I. While tandem mass spectrometry eliminates subunits A14 and A14.5 from 
both complexes, free Pol I also dissociates subunit AC40 at relatively low energy. These 
Figure 11. Rrn3 monomer still bind to Pol I. left: Gel Filtration pofile. right, SDS PAGE analysis of Peak1 (pk1), Peak 2 
(pk2) and Peak 3 (pk3) after TCA Precipitation. Pk 3 contains an unknown impurity from the Rrn3 sample. 
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results are consistent with previous dissociation experiments of Pol I (Geiger et al, 2010), 
and lead to a preliminary conclusion that Rrn3 binding to Pol I has a stabilizing effect on 
the Pol I subunit AC40, although, without further proof, this assumption remains 
speculative. 
 
3.2.2 Rrn3 does not bind subunits A43/14 alone 
It has been shown previously that Rrn3 interacts directly with Pol I subunits A43/14 and 
thereby forms a bridge between Pol I and the core factor, thus facilitating the recruitment 
of Pol I to the promoter (Peyroche et al, 2000). This interaction seems to be favored when 
Rrn3 is in an unphosphorylated state and Pol I is phosphorylated (Fath et al, 2001). This 
would lead to the conclusion that Rrn3 produced in E. coli, without posttranslational 
modifications should be able to bind A43 from an endogenous source, and probably also 
when A43 and Rrn3 are co-expressed in E. coli, as was shown previously (Peyroche et al, 
2000). In our experiments no stable or stoichiometric binding could be observed between 
Rrn3 and A43 alone, or the A43/14 heterodimer, from recombinant expression (Figure 12). 
However, as five of the mapped Pol I phosphosites are located in subunit A43 (Gerber et 
al, 2008), we assayed the impact of A43 phosphomimetic point mutations on the Rrn3-
A43 complex formation and stability. Strep-tagged Rrn3 was expressed and purified from 
E. coli, as well as A43 WT and variants S262/263D, 4P (S220D, S262/263D, S285D) and 5P 
(S208D, S220D, S262/263D, S285D). 
 
 
Figure 12. Pulldown binding assays. Rrn3 carrying a Strep-Tag was incubated with an excess of A43 or A43/14 
heterodimer or with the respective variants as indicated, with A43 and variants carrying an C-terminal His6-Tag. Proteins 
were bound to Ni-NTA beads, washed and eluted from a gravity flow column with 200 mM Imidazol. Except lane 3 and 4, 
where proteins were bound to Strep-beads, washed, and eluted with DTB. Flowthrough (ft) fractions containing 
unbound protein and Elution (el) fractions were analysed via an SDS page and stained with coomassie. 
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The A43 phosphomimetic variants were expressed and purified as a stable heterodimer 
with A14, but did not show an improved binding ability to Rrn3. These results suggest, that 
stable complex formation between Rrn3 and Pol I does either require a different pattern 
of posttranslational modifications, or an additional Pol I subunit as interaction partner. 
As an interaction between the Pol I specific subunits A49/34.5 and Rrn3 has been 
postulated, with the heterodimer triggering the release of Rrn3 upon entering the 
elongation phase (Albert et al, 2011; Beckouet et al, 2008), we also examined a possible 
direct interaction of Rrn3 with A49. Co-purification experiments were performed as 
described for the A43/14 heterodimer, but no interaction could be found. This result was 
expected, and supports the idea of a repulsive interaction between A49/34.5 and Rrn3, 
triggering the release of Rrn3 from elongating Polymerase. 
 
3.2.3 The Rrn3 structure exhibits a serine patch that is important for cell growth 
Eight serine residues, arranged in four pairs, cluster on the surface of the Rrn3 structure, 
which are later referred to as the ‘serine patch’ (Figure 13A). Six of these residues are 
conserved between yeast and human (Figure 6A). Residues S185 and S186 correspond to 
human residues S199 and T200, which are phosphorylated in vivo, preventing Pol I 
association and thus shutting down Pol I transcription (Mayer et al, 2005; Mayer et al, 
2004). Since the interaction of Pol I with TIF-IA depends on the phosphorylation status of 
TIF-IA (Bierhoff et al, 2008; Fath et al, 2001; Hoppe et al, 2009; Mayer et al, 2005; Mayer 
et al, 2004; Philimonenko et al, 2004; Schlosser et al, 2002; Zhao et al, 2003), we 
investigated whether the serine patch of Rrn3 is required for Pol I binding and whether 
phosphorylations in this patch have an effect on cell growth. We mutated the serines 
individually to alanine or aspartate, thereby disabling phosphorylation or mimicking a 
permanently phosphorylated state, respectively. Complementation assays in a Δrrn3 strain 
revealed that the Rrn3 mutation S145D causes severe slow growth on YPD plates under 
various conditions and in liquid culture (Figure 13 and 14A/B), whereas mutations of the 
other residues had no effect (Figure 13B). The phenotype was enhanced in the presence 
of rapamycin, an inhibitor of the TOR kinase pathway that regulates Pol I, and in the 
presence of cycloheximide, an inhibitor of protein biosynthesis (Figure 14A). This shows 
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the importance of the serine patch, and in particular S145, for cell growth, and suggests a 
conserved mechanism of Rrn3 phospho-regulation. 
 
 
 
3.2.4 The serine patch is involved in Pol I binding in vitro 
We expressed and purified the Rrn3 mutant S145D, which showed a growth defect in 
yeast (Figure 13B and 14A/B), and the mutant S185D, that corresponds to human S199D, 
which does not bind Pol I (Mayer et al, 2004). The purified Rrn3 mutants were tested for 
Figure 13. Surface serine patch. (A) serines in the patch are labeled in blue. The crosslinked loop and the dier 
interface are indicated. The orientation on the right is the same as in the docking model, Figure xx. (B) Rrn3 serine 
patch variants were cloned into a pRS315 vector by homologous recombination, transformed into the rrn3 shuffle 
strain and spotted in serial dilutions onto 5-FOA-containing plates, to shuffle out the Rrn3-expressing URA3 plasmid. 
Plates were incubated at 30°C and 25°C to test the additional effect of temperature stress.  
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their ability to form stable complexes with Pol I after size exclusion chromatography 
(Fig. 14C). Whereas wild-type Rrn3 bound Pol I in these assays, Rrn3 mutant S145D did not 
bind Pol I and the mutant S185D bound only weakly (Fig. 14C). Thus the serine patch of 
Rrn3 is involved in Pol I binding in vitro and phospho-mimetic mutations in this patch can 
impair Pol I binding. 
 
 
 
3.2.5 The Rrn3 serine patch is required for cell growth and promoter recruitment in vivo 
To investigate Pol I recruitment to the rDNA gene locus in vivo, we performed chromatin 
immunoprecipitation (ChIP) experiments. We prepared yeast strains with a genomically 
expressed C-terminal tandem affinity purification (TAP) tag on Pol I subunit A190 and 
expressing Rrn3 wild-type or mutant S145D from a plasmid, and determined Pol I 
occupancy at rDNA genes by ChIP (Figure 15). Pol I occupancy at all tested regions of the 
rDNA locus was strongly decreased in the strain expressing Rrn3 mutant S145D 
(Figure 15B), although protein levels were unchanged (Figure 15D). This shows that 
Figure 14.  (A) Yeast complementation assays reveal a critical function of Rrn3 residue S145 for cell growth. Growth of 
rrn3 mutants was further tested on plates containing 0.025 µg/ml rapamycin or 0.25 µg/ml cycloheximide. 
(B) A yeast strain expressing the Rrn3 mutant S145D exhibits a slow-growth phenotype in liquid culture (green). Growth 
of the same strain under the same conditions but expressing wild-type Rrn3 from the same plasmid is shown in blue 
(WT). 
(C) The serine patch is required for Pol I binding in vitro. Pol I was incubated with excess wild-type or mutant Rrn3 and 
subjected to size exclusion chromatography, which revealed two separated peaks (pk1, pk2) that were analyzed with 
Coomassie-stained SDS PAGE. In contrast to wild-type Rrn3 (WT), which forms a stable complex with Pol I in these 
assays, the Rrn3 mutants S185D and S145D bind Pol I weakly or not at all (pk1). The second peak corresponded to free 
excess Rrn3 proteins (pk2). 
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normal Pol I recruitment to rDNA in vivo requires an unphosphorylated S145 residue on 
Rrn3. We also tested whether the S145D mutation impairs Rrn3 recruitment to rDNA. We 
complemented the Δrrn3 strain with plasmids expressing TAP-tagged Rrn3 wild-type or 
mutant S145D. ChIP revealed that wild-type Rrn3 localizes to the rDNA promoter and the 
beginning of the transcribed region as shown before (Beckouet et al, 2008; Bier et al, 
2004; Claypool et al, 2004; Philippi et al, 2010), whereas occupancy with mutant S145D 
was decreased 5- to 10-fold (Figure 15C). These results indicate that S145 phosphorylation 
impairs cooperative recruitment of Rrn3 and Pol I to the rDNA gene in vivo. 
 
Figure 15. Rrn3 serine patch recruits Pol I to genes 
(A) For ChIP analysis, primer pairs complementary to five regions of the rDNA locus were used (indicated by arrows). 
ETS, external transcribed spacer; ITS, internal transcribed spacer; RDN18, region encoding the 18S rRNA; RDN25, region 
encoding the 25S rRNA. 
(B) ChIP analysis shows that the Rrn3 S145D mutation reduces Pol I occupancy at the rDNA locus. ChIP was carried out 
with haploid strain Y24975 (Δrrn3) expressing a plasmid encoding either Rrn3 wild-type (WT) or Rrn3 mutant S145D and 
carrying a C-terminal TAP tag on Pol I subunit A190. ChIP intensities over background are shown in a bar diagram. Errors 
were estimated from two biological replicate measurements. As a negative control, we used primers complementary to 
the open reading frame of the Pol II-transcribed gene adh1 (ADH1_ORF). 
(C) The Rrn3 S145D mutation reduces Rrn3 occupancy at the rDNA locus. ChIP was performed with a strain expressing 
the C-terminally TAP-tagged Rrn3 mutant S145D from plasmid pRS315. 
(D) Rrn3 S145D mutation does not change cellular Rrn3 protein levels according to western blot analysis with TAP-
tagged Rrn3 variants. The ratio of western blot signals for Rrn3 and tubulin was two-fold throughout, as calculated with 
ImageQuant TL 7.0 Image Analysis Software (GE Healthcare). 
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3.2.6 Rrn3 binds Pol I near subcomplex AC40/19 
To elucidate the molecular basis for Pol I-Rrn3 binding, we subjected the Pol I-Rrn3 
complex to chemical crosslinking and identified crosslinked lysines by MS (Leitner et al, 
2010). This experiment reveals proximal lysine residues on adjacent proteins in stable 
multiprotein complexes and allows positioning of crystal structures to obtain topological 
models of large polymerase-factor complexes (Chen et al, 2010). Pol I-Rrn3 complex was 
purified as described in 2.4.2 and crosslinked with a final concentration of 1.2 mM 
disuccinimidyl suberate. The crosslinked complex was subjected to a trypsin digest and 
crosslinked lysines were identified by MS. The MS data were of high quality, as crosslinks 
between Pol I subunits were explained with the Pol I model (Kuhn et al, 2007) and the 
Pol II structure (Armache et al, 2005). Details of the crosslinks within Pol I are described in 
a separate study (Jennebach et al, 2011). The analysis revealed two high-confidence 
crosslinks between Rrn3 and Pol I, connecting Rrn3 residue K558 to Pol I residues K582 
and K329 in subunits A190 and AC40, respectively (Figure 16B). The crosslinked Pol I 
residues were positioned on the ‘back’ of the homologous Pol II structure in the Rpb3/11 
heterodimer, which corresponds to the AC40/19 heterodimer, and in Rpb1, which is the 
corresponding Pol II subunit to A190. 
The interaction with subunit AC40 agrees with the effect that was seen in the native 
Masspec experiments (3.2.1), namely that subunit AC40 is somehow more stably bound in 
a Pol I-Rrn3 complex, than in free Pol I.  
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3.3 Model of a minimal RNA Polymerase I initiation Complex 
3.3.1 Model of the Pol I-Rrn3 complex 
To obtain a model for the Pol I-Rrn3 complex, we positioned the Rrn3 structure on the 
polymerase such that crosslinks were explained, and did not exceed a distance of 27.4 Å 
between Cα atoms of crosslinked lysines. The crosslinked Rrn3 residue K558 is part of the 
short mobile loop α20-α21 that follows the ordered residue G554, which was allowed to 
be in a distance up to 30.9 Å from crosslinked Pol I lysines (the theoretical maximum Cα 
distance of 27.4 Å plus 3.5 Å for mobile residues 555-558). Only one Rrn3 orientation 
positioned the serine patch towards Pol I, to explain the interaction data without 
producing protein clashes (Figure 16B).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. (A) crosslinking of the Pol I- Rrn3 complex. 10 µg of crossliked sample were analysed via SDS page and 
visualized with silver stain. concentrations of crosslinker are indicated above each lane. (B) Model of the Pol I-Rrn3 
complex based on lysine-lysine crosslinking and protein interaction data. Back view of a 12-subunit Pol I model that is 
based on the Pol II core structure (silver) (Armache et al, 2005) and the structure of subcomplex A14/43 (red/blue) 
(Kuhn et al, 2007; Tsai and Sigler, 2000). The Pol II core heterodimer Rpb3/11 that is homologous to the Pol I 
heterodimer AC40/19 is highlighted in red/yellow. The positioned Rrn3 structure (green) contains a lysine residue (K558) 
that is part of a short mobile loop following the ordered residue G554 (cyan dot) and crosslinks to two Pol I residues 
(cyan dots connected with dashed lines). Crosslinked positions in the Pol I core are revealed in the homologous Pol II 
structure; K582 in A190 corresponds to M437 in Rpb1, and K329 in AC40 corresponds to L259 in Rpb3 (cyan dots). 
Positions C92 and A159 in Rpb3, influencing the interaction of Pol II with the Mediator head module (Soutourina et al, 
2011) are indicated as grey spheres. 
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In the resulting model of the Pol I-Rrn3 complex, Rrn3 extends from the heterodimer 
AC40/19 alongside the RNA exit tunnel and dock domain up to A14/43, the counterpart of 
the Pol II subcomplex Rpb4/7. The model explains Rrn3 binding to the OB domain of 
subunit A43 (Peyroche et al, 2000), an early electron microscopic projection and 
colocalization of A43 and Rrn3 (Peyroche et al, 2000), the observation that Rrn3 can be 
fused to A43 in vivo maintaining the same growth rates as the wild-type strain (Laferte et 
al, 2006), and an apparently stabilizing effect of A14 on the Rrn3-Pol I interaction 
(Imazawa et al, 2005). 
It further came to our attention that the crosslinks that locate the C-terminal part of Rrn3 
on the Pol I surface structure, lie in proximity to two positions that affect binding of the 
mediator head module Med17 (Soutourina et al, 2011). 
  
3.3.2 Rrn7 is the TFIIB-related factor in the RNA Polymerase I initiation apparatus 
As crosslinking and mutational analysis helped to identify the location of Rrn3 to be close 
to the dock domain, we were encouraged to search for a homolog of the Pol II factor TFIIB 
in the Pol I initiation machinery, since TFIIB binds the Pol II dock domain (Chen and Hahn, 
2003). A TFIIB homolog in the Pol I system could thus represent an Rrn3 interaction 
partner. We examined the three subunits of the Pol I core factor, Rrn6, Rrn7, and Rrn11, 
with the HHPred structure prediction server (Soding et al, 2005). This revealed a clear 
homology of the N-terminal region of Rrn7 (residues 1-316) with TFIIB (E-value 0.028, 
probability score 93.6). The structured domains of TFIIB, the N-terminal zinc ribbon and 
the two C-terminal cyclin folds (Kosa et al, 1997; Kostrewa et al, 2009; Tsai and Sigler, 
2000) are present in Rrn7 (Figure 17) with a sufficient sequence homology to create a 
convincing model using MODELLER (Eswar et al, 2008) based on known TFIIB structures 
from different species (Kosa et al, 1997; Kostrewa et al, 2009; Liu et al, 2010; Tsai and 
Sigler, 2000). The predicted Rrn7 Zn-ribbon domain contains all four zinc-binding cysteine 
residues, with the C-terminal cysteine replaced by a functionally equivalent histidine, 
which are arranged in a tetrahedral conformation in the model, appropriate for 
coordination of a Zn ion. The C-terminal region of Rrn7 does not show homologies to 
known factors, similar to the TFIIB-related factor Brf1 in the Pol III system, which also 
contains a specific C-terminal region (Juo et al, 2003) (Figure 17B and 20). 
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Figure 17. (A) homology model of Rrn7 in comparison with TFIIB (Kostrewa et al, 2009). (B) Schematic representation of 
distinct structural domains in TFIIB and the homologous factors Rrn7 and Brf1 in the Pol I and Pol III systems, 
respectively. All three proteins exhibit an N-terminal zinc ribbon followed by two conserved cyclin folds. In addition, 
Rrn7 and Brf1 contain a specific C-terminal region 
 
3.3.3 Architecture of the Pol I initiation complex 
The discovery of Rrn7 as the TFIIB-related factor in the Pol I initiation apparatus allowed 
us to extend the current model to a minimal Pol I initiation complex (Figure 18). We 
included the above described model for Rrn7 on the basis of known TFIIB structures, 
assuming that Rrn7, TBP, and promoter DNA are positioned similar to the previously 
described Pol II initiation complex model (Kostrewa et al, 2009). The resulting model 
revealed that the N-terminal zinc ribbon domain of Rrn7 that is bound to the polymerase 
dock domain could contact Rrn3 between heat repeats H4 and H5 (Figure 18), which 
would further provide an explanation for the known interaction between the human 
homologs of Rrn3/TIF-IA and Rrn7/TAF168 (Miller et al, 2001). The model further suggests 
that the two other subunits of the core factor, Rrn6 and Rrn11, occupy positions between 
the Pol I clamp and subcomplexes A14/43 and dock domain. This location of the CF 
subunits explains known interactions of Rrn3 with Rrn6 in yeast (Peyroche et al, 2000) and 
TAF1110 in the human system (Miller et al, 2001) and moreover justifies an interaction 
between Rrn11 and TBP, as well as Rrn6-Rrn7 and Rrn11-Rrn7 as demonstrated previously 
(Lalo et al, 1996). 
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Figure 18. (A) Model of a minimal Pol I initiation complex. The Pol I-Rrn3 model in A was combined with the Pol II 
minimal initiation complex model containing TFIIB (light green, serving as a model for Rrn7), TBP (magenta), and closed 
promoter DNA (blue/cyan) (Kostrewa et al, 2009). Pol I and DNA are represented as molecular surfaces, whereas TBP, 
the Rrn7 model, and Rrn3 are shown as ribbons. The presumed location of the remaining core factor subunits Rrn6 and 
Rrn11 are indicated with a dashed circle. The view is from the back. Positions of phosphorylated serines outside the 
serine patch in human TIF-IA are indicated. 
(B) Top view of the model in C containing all proteins in surface representation. 
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The long-term goal of understanding how transcription initiation works and where 
evolution created differences and retained similarities requires examination of the three 
Polymerase systems and their transcription factors in molecular detail. By applying a 
combination of structural and functional methods, we elucidated the mechanism of Rrn3-
regulated Pol I initiation and the effect of this interaction on cell growth in S. cerevisiae. 
The structure of Rrn3 revealed a unique HEAT repeat fold and a surface serine patch 
comprising four pairs of serines. Rrn3 forms a dimer in solution, but binds Pol I as a 
monomer with the binding interface extending along the back of Pol I from subcomplex 
AC40/19 to A14/43. In our docking model, the Rrn3 serine patch faces the Pol I subunit 
A43 and a phosphomimetic mutant in this patch impairs cell growth, Pol I binding in vitro, 
and Pol I recruitment to the rDNA promoter in vivo. This results in a reduced Pol I 
occupancy on the whole gene and a loss of Rrn3 from the promoter. Bioinformatic analysis 
identified Rrn7 as a putative functional homolog of TFIIB, leading to a model of a minimal 
Pol I-Rrn3 initiation complex.  
The results obtained in this study recapitulate published data and converge on the 
molecular basis for Pol I initiation regulation by Rrn3. Our current model for this 
regulation suggests the following: during normal cell growth, the Rrn3 serine patch is not 
phosphorylated, enabling Rrn3 to bind Pol I, and resulting in stable Pol I recruitment to the 
rDNA promoter and efficient transcription initiation. During stress, phosphorylation of the 
serine patch impairs Rrn3 interaction with Pol I and thus Pol I recruitment to rDNA, 
resulting in a down-regulation of Pol I transcription, ribosome production, and cell growth. 
The phosphorylation of serine patch residues in human TIF-IA (Mayer et al, 2005; Mayer et 
al, 2004) argues for a conserved phospho-regulation mechanism of the Pol I-Rrn3 
interaction and Pol I initiation. We tried to address this by phosphosite mapping of 
endogenous Rrn3 by MS, but this strategy proved to be unsuccessful despite extensive 
efforts using either exponentially growing cells or cells entering stationary phase. 
Purification of a phosphorylated state of Rrn3 turned out to be particularly difficult, since 
upon growth arrest in stationary phase, under any other stress condition such as 
rapamycin or cycloheximide treatment or upon aminoacid depletion Rrn3 levels are 
dramatically reduced (Philippi et al, 2010), which are the exact circumstances under which 
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we expect phosphorylation. With these very low cellular Rrn3 levels, it was impossible to 
get highly pure protein, which is necessary for phosphosite mapping via Masspec. 
Phosphorylation of TIF-IA also occurs outside the conserved serine patch (Bierhoff et al, 
2008; Hoppe et al, 2009; Philimonenko et al, 2004; Zhao et al, 2003) (Figure 13A and 18). 
Phosphorylation of residues S633 and S649 in the TIF-IA C-terminal tail activates 
transcription (Zhao et al, 2003), and S635 phosphorylation abolishes TIF-IA interaction 
with the human core factor (Hoppe et al, 2009). This is consistent with our model, which 
indicates that the TIF-IA C-terminal region that is not present in yeast Rrn3 could be near 
the predicted core factor location (Figure 18). Phosphorylation of the N-terminal serine 
S44 activates mammalian TIF-IA (Mayer et al, 2004), whereas in Rrn3 from S. cerevisiae a 
complete deletion of its 47 N-terminal residues had no effect in in vivo complementation 
assays. Phosphorylations at S170 and S172 are required for TIF-IA dissociation from 
elongating Pol I (Bierhoff et al, 2008), and may interfere with exiting RNA, which is 
predicted to displace the Rrn7 zinc ribbon (Figure 18).  
Rrn3 dissociation also requires the A49/34.5 subcomplex (Albert et al, 2011; Beckouet et 
al, 2008), but it is unclear why. One hypothesis is, that the A49/34.5 heterodimer of one 
elongating Polymerase could contact Rrn3 bound to a succeeding polymerase and thereby 
facilitate its release (Albert et al, 2011). As the exact position of A49/34.5 still remains 
unclear, and no direct interaction between the heterodimer and Rrn3 has been found so 
far, we cannot support, nor disprove this hypothesis with our current knowledge. 
In yeast, the Pol I-Rrn3 interaction is additionally regulated through phosphorylation of 
the Pol I subunit A43 that faces Rrn3, while Rrn3 is predominantly phosphorylated in its 
free form (Fath et al, 2001).  
Taken together, current data converge on the view that both Rrn3 and TIF-IA are 
regulated by phosphorylation of a conserved surface serine patch, but further distinct 
phosphorylations in TIF-IA-specific regions and on Pol I additionally contribute to their 
function and regulation.  
Rrn3 apparently also has a post-recruitment function, since Pol I can be recruited without 
Rrn3 at low levels, but requires Rrn3 for initiation (Aprikian et al, 2001; Schnapp and 
Grummt, 1991; Schnapp et al, 1993). We predict that Rrn3 binding causes a 
conformational change in Pol I that induces an initiation-competent state. Electron 
microscopy of free Pol I revealed a ‘collapsed state’ of the clamp (Kuhn et al, 2007) that 
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would prevent the DNA template strand from entering the active center cleft. Rrn3 
binding may however hold the clamp in a position that allows template loading. Clamp 
positioning may additionally involve Pol I-specific surface features of the clamp and dock 
domains (Kuhn et al, 2007). 
Our results also suggest that cells contain a reservoir of Rrn3 dimers that do not bind Pol I. 
The presence of serine residues S444 and S448 in the dimer interface further suggested 
that interface phosphorylation could release Rrn3 monomers that bind Pol I. However, the 
phospho-mimetic dimer-disrupting Rrn3 mutation S444/S448D had no phenotype in yeast 
(Figure 8), providing at present no evidence for regulated Rrn3 dimerization in vivo. 
Finally, with the data obtained in this study we are able to extend the unifying 
evolutionary view of transcription initiation in eukaryotic cells. 
Since regions in Pol I and Pol III subunits resemble parts of the Pol II initiation factors TFIIE 
and TFIIF (Geiger et al, 2010; Kassavetis et al, 2010; Lefevre et al, 2010; Vannini et al, 
2010), and transcription initiation by archaeal Pol, Pol II, and Pol III additionally requires 
TBP and TFIIB homologs (Colbert and Hahn, 1992; Kassavetis et al, 2005), it was always 
puzzling why the Pol I system lacks a factor related to TFIIB. The previously undetected 
predicted homology of the core factor subunit Rrn7 with TFIIB provides this missing link.  
It now appears that the initiation complexes of both Pol I and Pol III resemble the core of 
the Pol II-TBP-TFIIB/E/F complex.  
While this work was about to be completed, two consistent studies were published 
showing a functional homology between Rrn7 or its human ortholog TAF1B with TFIIB and 
Brf1. This was done by examining the effect of domain swaps between TFIIB, Brf1 and 
Rrn7, and by a functional analysis of several mutants in the Pol I dock domain or the Rrn7 
Zn-ribbon (Knutson and Hahn, 2011; Naidu et al, 2011), in full agreement with our results. 
The similarity in transcription initiation complex topology may extend to coactivators. 
Electron microscopy and crosslinking in combination with mutational analysis indicates 
that the Mediator head subunit Med17 binds at the Rpb3/11 subcomplex of Pol II 
(Soutourina et al, 2011; Takagi et al, 2006), a position close to the location of the 
C-terminal part of Rrn3 on Pol I. Hence, regulatory cofactors differ in structure, but may 
still use the same molecular targets on conserved core initiation complexes. 
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In this study, the high resolution structure of the central Pol I initiation factor Rrn3 was 
solved and revealed a new class of HEAT repeat proteins directly involved in Polymerase 
interaction. A structural biology hybrid approach combining SAXS, native-MS, X-ray and 
crossslinking-MS analysis, together with functional data of a mutagenesis study was 
applied. The obtained results firstly revealed a model for Rrn3 dimerization in solution and 
disruption of this dimer upon Pol I binding, secondly provided a model for Rrn3-Pol I 
interaction, thirdly indicated a possible regulation mechanism for the Pol I-Rrn3 
interaction that is conserved between yeast and human, and finally led to a new model for 
a minimal Pol I initiation complex, including Rrn7 as the homolog of TFIIB in the Pol I 
transcription system.  
It has been known for some time that Rrn3 binds to the Pol I subunits A43/14, but the 
docking model provided here now offers new insight into the Pol I-Rrn3 interaction, which 
involves a much broader interface than previously expected. However, new questions 
arise from these findings. As discussed before, Rrn3 might interact with the Pol I clamp to 
ensure an “open” state that allows entering of the DNA template strand and thereby 
facilitates efficient transcription initiation. Further, the position of Rrn3 on the Pol I 
surface close to the RNA exit channel theoretically allows contact of Rrn3 with the newly 
synthesized rRNA, and a positively charged stretch on the Rrn3 surface further supports 
this idea. However, preliminary electrophoretic mobility shift assays did not reveal an 
interaction of Rrn3 with a random dsDNA, ssDNA, or RNA template. Still, these 
experiments could be further optimized, and the possibility of an interaction of Rrn3 with 
a specific rRNA template and release of Rrn3 from the elongating Pol I in complex with the 
nascent rRNA would be an interesting question to address.  
Our current model, comprising Pol I, Rrn3, TBP and Rrn7 with DNA, provides an ideal basis 
for further investigations concerning the additional factors that are required for Pol I 
initiation. To date very little is known about the core factor subunits Rrn6 and Rrn11 that 
are interaction partners of Rrn7 and TBP.  
Extensive trials have been made in the past to purify several rationally designed Rrn7 
constructs from a recombinant E. coli expression system. All trials were fruitless, most 
likely due to a lack of stability of the protein alone, without its binding partners. 
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Consequently, the core factor subunits should be purified as a complex of a least two 
subunits, as very strong interactions between the subunits have been proved (Keener et 
al, 1998; Lalo et al, 1996; Lin et al, 1996). A possible stabilizing effect of TBP on the core 
factor is also conceivable, as it specifically interacts individually with Rrn6, Rrn7 and Rrn11 
(Lalo et al, 1996; Steffan et al, 1996). 
In order to follow up on this study and to establish a more comprehensive view of the Pol I 
initiation complex, a structural and functional investigation of the core factor is clearly the 
next step to be made. Examination of the additional subunits Rrn6 and Rrn11 and their 
interaction with the initiation-competent Pol I, and comparison of the results to 
characterized Pol II transcription factors and coactivators will further help to understand 
connections and differences between the three Polymerase systems, and to understand 
their evolutionary relationship. 
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6.1 EM studies on the Pol I-Rrn3 complex 
Before we succeeded to map the location of Rrn3 on the surface of Pol I through 
mutational analysis in combination with crosslinking, an attempt was started to locate 
Rrn3 on the surface of a Pol EM map. Therefore Pol I- Rrn3 complexes were prepared as 
described in 2.4.2 and Cryo-EM data was collected and processed from these samples as 
described in 2.4.7. 
During refinement only slight differences to the reference EM density calculated from a 
modified Pol II structure could be observed. Assuming that the homologous Pol I subunits 
would assemble similar to the Pol II subunits, the additional Pol I subunits A49/34.5 and 
the bound factor Rrn3 should be clearly visible as additional densities on the surface. In 
Figure 19 the initial particle selection and the Rrn3-Pol I docking model fitted into the 
resulting EM density is depicted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Cryo EM of Pol I-Rrn3 complex. (A) EM micrographs in negative stain of Pol I-Rrrn3 complex in two 
different concentrations to evaluate the sample quality for cryo-EM. (B) EM micrograph of Pol I-Rrn3 in vitrified ice, 
white circles indicate particles. (C) single particle images selected with EMAN2. (D) Cryo-EM reconstruction of Pol I- 
Rrn3. The 10 subunit Pol II core homology model, the A43/14 crystal structure and the docked Rrn3 crystal structure 
shown as ribbon model were fitted into the map. 
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The EM reconstruction that was obtained in this preliminary experiment using 11503 
particles could not support the presence of the additional Pol I subunits A49/34.5, neither 
is an extra density visible that would clearly represent a bound Rrn3, at the position it was 
located by cosslinking and mutational analysis. Besides possible problems concerning data 
collection and data processing certain biochemical properties could have led to this 
observation. Since it is known, that the A49/34.5 heterodimer can dissociate from Pol I 
(Geiger et al, 2010; Huet et al, 1976) and is therefore represented in a substoichiometric 
manner in the endogenous enzyme, we might have used a heterogeneous sample for data 
collection, which will lead to loss of information, without further specific sorting of the 
particles. The same problem might have occurred for the Rrn3 complexation. As there is 
only little known about the stability of the Pol I-Rrn3 complex in vitro it is to presume, that 
Rrn3 at least partially dissociated from the complex and the sample is additionally 
heterogeneous in this respect. From a sample with these high variabilities, it is hard to 
draw clear conclusions, and further improvements in sample preparation and data 
processing are indispensable, also when to aiming at an EM reconstruction of a complete 
Pol I PIC. 
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6.2 Pol I Phosphopeptide mapping 
The prerequisites for a stable interaction between Rrn3 and Pol I in vivo have been 
extensively studied in the mammalian system, and several pathways seem to regulate this 
interaction through specific phosphorylations of Rrn3/ TIF-IA. In the yeast system it has 
been shown that Rrn3 is predominantly phosphorylated in its free form but Pol I 
phosphorylations are necessary to form a stable Pol I-Rrn3 complex (Fath et al, 2001). 
Several Phosphosites have been mapped on the Pol I surface (Table 17) (Gerber et al, 
2008). 
Table 17 mapped Pol I phosphosites (Gerber et al, 2008) 
Subunit  Sequence  phosphosite 
A190 ADSFFMDVLVVPPTR S354 
 DSFFTR S685 
 GSNVNVSQIMCLLGQQALEGR S936 or S941 
A43 FSFGNR S208 
 SLGHWVDSNGEPIDGK S220 
 VVSVDGTLISDADEEGNGYNSSR S262 or S263 
 IVFDDEVSIENK S285 
A34.5 DYVSDSDSDDEVISNEFSIPDGFKK S10/S12/S14 
ABC23 ALQISMNAPVFVDLEGETDPLR S102 
AC19 HIQEEEEQDVDMTGDEEQEEEPDREK T33 
 LLTQATSEDGTSASFQIVEEDHTLGNALR T51 or T54 or S55 
 
 
To facilitate assembly of stable Pol I-Rrn3 complexes from recombinantly produced Rrn3 
and endogenous Pol I, we purified Pol I with Phosphatase inhibitors, as described in 2.4.1. 
In order to get an idea which phosphosites were preserved through this procedure, we 
performed phosphopeptide mapping via Masspec, using Pol I samples purified with or 
without phosphatase inhibitors, respectively (Table 18 and 19).  
 
Table 18. Pol I phosphosites, purification with phosphatase inhibitors 
Subunit  Sequence  Phosphosite 
A14 KETSIGVSATGGK 120;121
1,4 
A43 IVFDDEVSIENK 262;263;
2 
 VVSVDGTLISDADEEGNGYNSSR 285
2 
A49 RSVSEIEIESVQDQPSVAVGSFFK 8
1,4 
AC19 HIQEEEEQDVDMTGDEEQEEEPDREK 33
2 
A190 KLDGSNEASANDEESFDVGRNPTTRPK 287
2,4 
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Table 19. Pol I phosphosites, purification without phosphatase inhibitors 
Subunit  Sequence  Phosphosite 
A14 KETSIGVSATGGK 121
1,4 
A49 RSVSEIEIESVQDQPSVAVGSFFK 8
1,4 
AC19 TATEVTPQEPK 15
3,4 
Rpb12 SREGFQIPTNLDAAAAGTSQAR 2
3,4 
A135 IFIDDSQIWEDGQGNK 1156
3,4 
1
 Phosphosites identical in both samples, with and without phosphatase inhibitors 
2
 Phosphosites only identified in the sample purified with phosphatase inhibitors 
3
 Phosphosites only identified in the sample purified without phosphatase inhibitors 
4
 New Phosphosites that have not been published previously 
 
These experiments revealed a few new phosphosites that are distributed over the 
Polymerase surface in subunits A14, A49, AC19, Rpb12, A135 and A190. Pol I purified 
without Phosphatase inhibitors is not completely dephosphorylated, in contrary, some 
phosphosites were detected in this sample, which are not present in the sample that was 
treated with phosphatase inhibitors. However, concerning the Rrn3 interaction, one could 
draw the conclusion, that phosphorylations of subunit A43 at positions 262, 263 and 285, 
which are only observed in the sample treated with phosphatase inhibitors during 
purification, might affect Rrn3 binding. 
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6.3 Rrn7 structure prediction and modeling 
Rrn7 was identified as the homolog of TFIIB with the HHPred structure prediction server,  
and a high structural homology to the TFIIB cyclin folds was predicted for residues 117-317 
in Rrn7, and a weak homology of the Rrn7 N-terminus to the TFIIB Zn-ribbon. The essential 
Cysteine residues could be aligned and lie in a tetrahedral arrangement in the modeled 
Zn-ribbon. The first cyclin fold also shows a convincing homology, as many hydrophobic 
residues are conserved between TFIIB, Brf1 and Rrn7. Only the last two helices in the 
second cyclin fold are less conserved. The N-terminal part of Rrn7 could not clearly be 
aligned with the Brf1 C-terminus. The alignment depicted in Figure 20 was used to model 
Rrn7 with Modeller, using Rrn7 residues 1-317. 
   
Figure 20.  Alignment of S.c TFIIB, Brf1 and Rrn7. The N-termini of the sequences were arranged in a way that the 
conserved cysteines in the Zn-ribbon are aligned. Further, the two cyclin folds were arranged in order to match both 
the secondary structure predictions and the alignment obtained from HHpred. The structurally conserved sequence 
that encompasses the two cyclin folds is highlighted in light green. Similar small aliphatic and hydrophobic residues are 
accentuated in green, identical residues in dark green. The secondary structure elements were derived from yeast and 
human TFIIB (Liu et al, 2010), helices from cyclin1 are depicted in blue, from cyclin2 in lilac above the sequence 
alignment. The Brf1 C-terminal helices were derived from the Brf1 structure (Juo et al, 2003) and are depicted as brown 
cylinders above the alignment. 
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6.4 Core Factor purification 
The Pol I core factor (CF) comprises subunits Rrn6, Rrn7 and Rrn11, essential for Pol I 
transcription in vivo, which form a stable 200 kDa protein complex. Rrn7 was identified as 
the homolog of TFIIB, and a structural model could be obtained. For Rrn11 structural 
predictions using HHpred did not yet give a clear hint, whereas 400 aminoacids (residues 
169-569) of Rrn6 could be predicted to form a ß-propeller or a WD40 repeat domain, a 
structural feature known to coordinate multi-protein complex assemblies. 
Several attempts were made to express the single subunits in E. coli without a proper 
expression yields, or yielding aggregated proteins. Here a new approach was made by 
expressing all three subunits in parallel in E. coli assuming that the proteins need their 
binding partners for proper folding and stability. Therefore, Rrn6 and Rrn11 were cloned 
into one plasmid, separated by an additional ribosomal binding site and a TATA sequence. 
The sequences were cloned in either pET28, carrying a Kanamycin resistance cassette, and 
resulting in an N-terminal His6-Tag on Rrn6 and a C-terminal His6-Tag on Rrn11, or in 
pET21, carrying an Ampicillin resistance cassette and expressing Rrn6 without a Tag and 
Rrn11 with a C-terminal His6-Tag. Rrn7 was cloned into either pET28 or pET21 resulting 
accordingly in either an N-terminal or a C-terminal His6-Tag. Transformation of an E. coli 
expression strain was then performed with two plasmids carrying two different antibiotic 
resistance cassettes, expressing Rrn7 and Rrn6/Rrn11, respectively. 
Using this expression method a better yield could be obtained and the core factor seems 
to bind as a stoichiometric complex to the Ni-NTA affinity column, even when Rrn6 does 
not carry a His6-Tag, proving that we are able to express and purify a stable trimeric 
complex recombinantly.  
However, there are still substantial problems as the complex is not pure after the affinity 
purification step, and one major E. coli protein impurity, identified as ArnA, could not yet 
be removed through subsequent chromatography steps (Figure 21).  
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Figure 21. Core Factor purification 
(A) Ni-NTA elution profile after expression of Rrn6/Rrn11 from pET21 and Rrn7 from pET28. Centrifuged cell lysate was 
loaded onto a gravity flow column as described in 2.2.5 and eluted with increasing concentrations of imidazol as 
indicated above each lane. (B) Mono Q elution profile. Elution fractions from the affinity purification step, containing 
the desired proteins, were subjected to an ion exchange chromatography. Proteins eluted from 150 mM to 400 mM 
NaCl. After both purification steps proteins were identified via masspec. Results are indicated as blue and red labels. 
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bp   base pairs 
BSA   bovine serum albumin 
CHX   Cycloheximide 
CV   column volumes 
Da   dalton 
DMSO  dimethyl sulfoxide 
DTT   1,4-dithio-D,L-threitol 
E. coli   Escherichia coli 
EM   electron microscopy 
ETS   external transcribed spacer 
5-FOA  5-Fluoroorotic acid 
GTF   general transcription factor 
HEPES   N-2-hydroxyethylpiperazine-N’-2-ethane sulfonic acid 
IGS   intergenic spacer 
IPTG   Isopropyl-_-D-thiogalactopyranoside 
IM-MS  ion mobility mass spectrometry 
ITS   internal transcribed spacer 
kDa   kilo dalton 
LB   Luria-Bertani (media) 
MCS   multiple cloning site 
MES   (2-(N-morpholino)ethanesulfonic acid) 
MOPS   4-morpholinepropanesulfonic acid 
MW   molecular weight 
NaCl   sodium chloride 
Ni-NTA  nickel nitrilotriacetic acid 
ODX   optical density at a wavelength of X nm 
ORF   open reading frame 
PAGE   polyacrylamide gel electrophoresis 
PBS   phosphate buffered saline 
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 7 Abbreviations 
PDB   Protein Data Bank 
PEG   Polyethylene glycol 
pH   (potentia hydrogenii) measure of acidity 
PIC   pre-initiation complex 
Pol   RNA polymerase 
rpm   rounds per minute 
rapa   Rapamycin 
rRNA   ribosomal RNA 
SAXS   Small angle X-ray scattering 
S. cerevisiae  Saccharomyces cerevisiae 
S. pombe  Schizosaccharomyces pombe 
SDS   sodium dodecylsulfate 
SL1  Selectivity factor 1 
SLS   static light scattering 
SLS   Swiss light source 
SOB   Super Optimal Broth (media) 
SOC   Super Optimal broth with Catabolite repression (media) 
TAF   TBP-associated factor 
TB  Terrific Broth (media) 
TCEP   tris(2-carboxyethyl)phoshine hydrochloride 
TIF   transcription initiation factor 
TF   transcription factor 
TOR   Target of Rapamycin 
Tris   tris-(hydroxymethyl)-aminomethane 
UAF  upstream activating factor 
UBF  upstream binding factor 
wt   wild type 
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